{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:11:22Z","timestamp":1790392282694,"version":"4.1.0"},"reference-count":295,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"crossref","award":["2023JJ3089"],"award-info":[{"award-number":["2023JJ3089"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"crossref","award":["2024JJ5560"],"award-info":[{"award-number":["2024JJ5560"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82473299"],"award-info":[{"award-number":["82473299"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Hematol Oncol"],"DOI":"10.1186\/s40164-026-00752-w","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T04:45:49Z","timestamp":1770266749000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The influence of neuro-tumor interactions on tumorigenesis and therapeutic response"],"prefix":"10.1186","volume":"15","author":[{"given":"Xiaokang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanliang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liugen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongfei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhimanyu","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juanni","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"key":"752_CR1","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12943-025-02246-5","volume":"24","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Liao Q, Wen X, Fan J, Yuan T, Tong X, Jia R, Chai P, Fan X. Hijacking of the nervous system in cancer: mechanism and therapeutic targets. Mol Cancer. 2025;24:44.","journal-title":"Mol Cancer"},{"key":"752_CR2","doi-asserted-by":"publisher","first-page":"217483","DOI":"10.1016\/j.canlet.2025.217483","volume":"612","author":"J Zhao","year":"2025","unstructured":"Zhao J, Cheng L, Yang J, Xu F, Qi W, Liao K, Zhou L, Cao L, Chen J, Lin Y. Tumor-nerve interactions in cancer regulation and progression. Cancer Lett. 2025;612:217483.","journal-title":"Cancer Lett"},{"key":"752_CR3","doi-asserted-by":"publisher","first-page":"115230","DOI":"10.1016\/j.ejca.2025.115230","volume":"217","author":"ADJ Pearson","year":"2025","unstructured":"Pearson ADJ, Mueller S, Filbin MG, Grill J, Hawkins C, Jones C, Donoghue M, Drezner N, Weiner S, Russo M, et al. Paediatric strategy forum for medicinal product development in diffuse midline gliomas in children and adolescents ACCELERATE in collaboration with the European medicines agency with participation of the food and drug administration. Eur J Cancer. 2025;217:115230.","journal-title":"Eur J Cancer"},{"key":"752_CR4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1158\/2159-8290.CD-24-0194","volume":"15","author":"V Venkataramani","year":"2025","unstructured":"Venkataramani V, Yang Y, Ille S, Suchorska B, Loges S, Tost H, Sahm F, Pfister SM, Trumpp A, Krieg SM, et al. Cancer neuroscience of brain tumors: from multicellular networks to neuroscience-Instructed cancer therapies. Cancer Discov. 2025;15:39\u201351.","journal-title":"Cancer Discov"},{"key":"752_CR5","doi-asserted-by":"publisher","first-page":"217431","DOI":"10.1016\/j.canlet.2024.217431","volume":"611","author":"C Xu","year":"2025","unstructured":"Xu C, Jiang C, Tian Y, Liu Y, Zhang H, Xiang Z, Xue H, Gu L, Xu Q. Nervous system in colorectal cancer. Cancer Lett. 2025;611:217431.","journal-title":"Cancer Lett"},{"key":"752_CR6","doi-asserted-by":"publisher","first-page":"217132","DOI":"10.1016\/j.canlet.2024.217132","volume":"598","author":"Y Liu","year":"2024","unstructured":"Liu Y, Yin S, Lu G, Du Y. The intersection of the nervous system and breast cancer. Cancer Lett. 2024;598:217132.","journal-title":"Cancer Lett"},{"key":"752_CR7","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/s41573-024-01017-z","volume":"23","author":"D Yaniv","year":"2024","unstructured":"Yaniv D, Mattson B, Talbot S, Gleber-Netto FO, Amit M. Targeting the peripheral neural-tumour microenvironment for cancer therapy. Nat Rev Drug Discov. 2024;23:780\u201396.","journal-title":"Nat Rev Drug Discov"},{"key":"752_CR8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s10555-025-10241-x","volume":"44","author":"A Sattler","year":"2025","unstructured":"Sattler A, Korzun T, Gupta K, Diba P, Kyprianou N, Eksi SE. Sympathetic nerve signaling rewires the tumor microenvironment: a shift in microenvironmental-ity. Cancer Metastasis Rev. 2025;44:25.","journal-title":"Cancer Metastasis Rev"},{"key":"752_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ccell.2024.09.014","volume":"43","author":"WL Hwang","year":"2025","unstructured":"Hwang WL, Perrault EN, Birbrair A, Mattson BJ, Gutmann DH, Mabbott DJ, Cukierman E, Repasky EA, Sloan EK, Zong H, et al. Integrating priorities at the intersection of cancer and neuroscience. Cancer Cell. 2025;43:1\u20135.","journal-title":"Cancer Cell"},{"key":"752_CR10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1227\/neu.0000000000003039","volume":"96","author":"JD Bernstock","year":"2025","unstructured":"Bernstock JD, Gerstl JVE, Chen JA, Johnston BR, Nonnenbroich LF, Spanehl L, Gessler FA, Valdes PA, Lu Y, Srinivasan SS, et al. The case for neurosurgical intervention in cancer neuroscience. Neurosurgery. 2025;96:10\u20137.","journal-title":"Neurosurgery"},{"key":"752_CR11","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1101\/gad.352288.124","volume":"38","author":"JC Borniger","year":"2024","unstructured":"Borniger JC. Cancer neuroscience at the brain\u2013body interface. Genes Dev. 2024;38:787\u201392.","journal-title":"Genes Dev"},{"key":"752_CR12","doi-asserted-by":"publisher","first-page":"217492","DOI":"10.1016\/j.canlet.2025.217492","volume":"612","author":"Y Huang","year":"2025","unstructured":"Huang Y, Zhou X, Liu J, Cao Y, Fu W, Yang J. Emerging neuroimmune mechanisms in cancer neuroscience. Cancer Lett. 2025;612:217492.","journal-title":"Cancer Lett"},{"key":"752_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1084\/jem.2.1.1","volume":"2","author":"HH Young","year":"1897","unstructured":"Young HH. On the presence of nerves in tumors and of other structures in them as revealed by a modification of Ehrlich\u2019s method of vital staining with methylene blue. J Exp Med. 1897;2:1\u201312.","journal-title":"J Exp Med"},{"key":"752_CR14","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.cell.2020.03.034","volume":"181","author":"M Monje","year":"2020","unstructured":"Monje M, Borniger JC, D\u2019Silva NJ, Deneen B, Dirks PB, Fattahi F, Frenette PS, Garzia L, Gutmann DH, Hanahan D, et al. Roadmap for the emerging field of cancer neuroscience. Cell. 2020;181:219\u201322.","journal-title":"Cell"},{"key":"752_CR15","doi-asserted-by":"publisher","first-page":"216986","DOI":"10.1016\/j.canlet.2024.216986","volume":"594","author":"L Wang","year":"2024","unstructured":"Wang L, Ge J, Han H, Jia Y, Qin Y. Crosstalk between the nervous system and tumor microenvironment: functional aspects and potential therapeutic strategies. Cancer Lett. 2024;594:216986.","journal-title":"Cancer Lett"},{"key":"752_CR16","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.imlet.2020.07.010","volume":"227","author":"N Cortese","year":"2020","unstructured":"Cortese N, Rigamonti A, Mantovani A, Marchesi F. The neuro-immune axis in cancer: relevance of the peripheral nervous system to the disease. Immunol Lett. 2020;227:60\u20135.","journal-title":"Immunol Lett"},{"key":"752_CR17","doi-asserted-by":"publisher","first-page":"188828","DOI":"10.1016\/j.bbcan.2022.188828","volume":"1877","author":"J Hu","year":"2022","unstructured":"Hu J, Chen W, Shen L, Chen Z, Huang J. Crosstalk between the peripheral nervous system and breast cancer influences tumor progression. Biochim Et Biophys Acta (BBA) - Reviews Cancer. 2022;1877:188828.","journal-title":"Biochim Et Biophys Acta (BBA) - Reviews Cancer"},{"key":"752_CR18","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/s10020-025-01333-z","volume":"31","author":"F Xiong","year":"2025","unstructured":"Xiong F, Xiao B-l, Wang Q, Liu K, Wu H-w, Jing C. Tong K-n, Zhang Z-t, Guo W: nerve growth factor: what can surgeons and oncologists learn from a neurological and psychological biomarker? Mol Med. 2025;31:276.","journal-title":"Mol Med"},{"key":"752_CR19","doi-asserted-by":"publisher","first-page":"e70147","DOI":"10.1002\/cbf.70147","volume":"43","author":"A Swamy","year":"2025","unstructured":"Swamy A, Ravikumar K, Pious M, Job A, John D, Shankarappa SA. Nerve adaptations in the tumor microenvironment. Cell Biochem Funct. 2025;43:e70147.","journal-title":"Cell Biochem Funct"},{"key":"752_CR20","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1038\/s41556-022-00978-w","volume":"24","author":"C Pan","year":"2022","unstructured":"Pan C, Winkler F. Insights and opportunities at the crossroads of cancer and neuroscience. Nat Cell Biol. 2022;24:1454\u201360.","journal-title":"Nat Cell Biol"},{"key":"752_CR21","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/j.cell.2023.02.002","volume":"186","author":"F Winkler","year":"2023","unstructured":"Winkler F, Venkatesh HS, Amit M, Batchelor T, Demir IE, Deneen B, Gutmann DH, Hervey-Jumper S, Kuner T, Mabbott D, et al. Cancer neuroscience: state of the field, emerging directions. Cell. 2023;186:1689\u2013707.","journal-title":"Cell"},{"key":"752_CR22","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.trecan.2023.07.009","volume":"9","author":"S Heuer","year":"2023","unstructured":"Heuer S, Winkler F. Glioblastoma revisited: from neuronal-like invasion to pacemaking. Trends Cancer. 2023;9:887\u201396.","journal-title":"Trends Cancer"},{"key":"752_CR23","doi-asserted-by":"publisher","first-page":"e70097","DOI":"10.1111\/cns.70097","volume":"30","author":"W Lv","year":"2024","unstructured":"Lv W, Wang Y. Neural influences on tumor progression within the central nervous system. CNS Neurosci Ther. 2024;30:e70097.","journal-title":"CNS Neurosci Ther"},{"key":"752_CR24","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s00701-024-06406-2","volume":"167","author":"M Westphal","year":"2025","unstructured":"Westphal M, Drexler R, Maire C, Ricklefs F, Lamszus K. Cancer neuroscience and glioma: clinical implications. Acta Neurochir. 2025;167:2.","journal-title":"Acta Neurochir"},{"key":"752_CR25","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1146\/annurev-neuro-111020-092702","volume":"45","author":"MB Keough","year":"2022","unstructured":"Keough MB, Monje M. Neural signaling in cancer. Annu Rev Neurosci. 2022;45:199\u2013221.","journal-title":"Annu Rev Neurosci"},{"key":"752_CR26","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s11060-024-04577-7","volume":"166","author":"MLM Zimmermann","year":"2024","unstructured":"Zimmermann MLM, Breedt LC, Centeno EGZ, Reijneveld JC, Santos FAN, Stam CJ, van Lingen MR, Schoonheim MM, Hillebrand A, Douw L. The relationship between pathological brain activity and functional network connectivity in glioma patients. J Neurooncol. 2024;166:523\u201333.","journal-title":"J Neurooncol"},{"key":"752_CR27","doi-asserted-by":"publisher","first-page":"11587","DOI":"10.1523\/JNEUROSCI.2033-07.2007","volume":"27","author":"D Isaev","year":"2007","unstructured":"Isaev D, Isaeva E, Shatskih T, Zhao Q, Smits NC, Shworak NW, et al. Role of extracellular sialic acid in regulation of neuronal and network excitability in the rat hippocampus. J Neurosci. 2007;27:11587\u201394.","journal-title":"J Neurosci"},{"key":"752_CR28","first-page":"1963","volume":"25","author":"U Kuliesiute","year":"2023","unstructured":"Kuliesiute U, Joseph K, Straehle J, Madapusi Ravi V, Kueckelhaus J, Kada Benotmane J, Zhang J, Vlachos A, Beck J, Schnell O, et al. Sialic acid metabolism orchestrates transcellular connectivity and signaling in glioblastoma. Neurooncology. 2023;25:1963\u201375.","journal-title":"Neurooncology"},{"key":"752_CR29","doi-asserted-by":"publisher","first-page":"fcad040","DOI":"10.1093\/braincomms\/fcad040","volume":"5","author":"AS Mandal","year":"2023","unstructured":"Mandal AS, Brem S, Suckling J. Brain network mapping and glioma pathophysiology. Brain Commun. 2023;5:fcad040.","journal-title":"Brain Commun"},{"key":"752_CR30","doi-asserted-by":"publisher","first-page":"3654","DOI":"10.1093\/brain\/awac180","volume":"145","author":"T Numan","year":"2022","unstructured":"Numan T, Breedt LC, Maciel BAPC, Kulik SD, Derks J, Schoonheim MM, Klein M, de Witt Hamer PC, Miller JJ, Gerstner ER, et al. Regional healthy brain activity, glioma occurrence and symptomatology. Brain. 2022;145:3654\u201365.","journal-title":"Brain"},{"key":"752_CR31","doi-asserted-by":"publisher","first-page":"e18761429254358","DOI":"10.2174\/0118761429254358231120135400","volume":"17","author":"W Wang","year":"2024","unstructured":"Wang W, Xu X, Yang M, Jiang M, Wang D, Tang C, Wei W, Chen J. Ginsenoside compound K reduces Psoriasis-related inflammation by activation of the glucocorticoid receptor in keratinocytes. Curr Mol Pharmacol. 2024;17:e18761429254358.","journal-title":"Curr Mol Pharmacol"},{"key":"752_CR32","doi-asserted-by":"publisher","first-page":"e18761429280572","DOI":"10.2174\/0118761429280572240311060851","volume":"17","author":"R Liang","year":"2024","unstructured":"Liang R, Ge W, Song X, Wang H, Cui W, Zhang X, Wei Z, Li G. Paeoniflorin alleviates anxiety and visceral hypersensitivity via HPA axis and BDNF\/TrkB\/PLC\u03b31 pathway in maternal Separation-induced IBS-like rats. Curr Mol Pharmacol. 2024;17:e18761429280572.","journal-title":"Curr Mol Pharmacol"},{"key":"752_CR33","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41392-025-02241-8","volume":"10","author":"T Pu","year":"2025","unstructured":"Pu T, Sun J, Ren G, Li H. Neuro-immune crosstalk in cancer: mechanisms and therapeutic implications. Signal Transduct Target Therapy. 2025;10:176.","journal-title":"Signal Transduct Target Therapy"},{"key":"752_CR34","first-page":"207","volume":"1","author":"X Tang","year":"2025","unstructured":"Tang X, Pang Y, Zhu P, Zhang Z, Guo S, Wei Z, Wang W, Ning B. Cell apoptosis and Glucocorticoid-Induced osteonecrosis. Med Res. 2025;1:207\u201325.","journal-title":"Med Res"},{"key":"752_CR35","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.cpan.2025.01.004","volume":"21","author":"H Fan","year":"2025","unstructured":"Fan H, Wang C, Liu S, Li Y, Xu Z. Therapeutic potential of natural products in stress granules: underlying molecular mechanisms and future perspectives. Curr Pharm Anal. 2025;21:88\u201399.","journal-title":"Curr Pharm Anal"},{"key":"752_CR36","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s00401-006-0100-x","volume":"112","author":"C Piette","year":"2006","unstructured":"Piette C, Munaut C, Foidart J-M, Deprez M. Treating gliomas with glucocorticoids: from bedside to bench. Acta Neuropathol. 2006;112:651\u201364.","journal-title":"Acta Neuropathol"},{"key":"752_CR37","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1158\/1541-7786.MCR-20-1068","volume":"20","author":"Y Hu","year":"2022","unstructured":"Hu Y, Jiang Y, Zhang Z, Wang J, Zhang B, Gong L, et al. Oncogenic activity of glucocorticoid receptor \u03b2 is controlled by ubiquitination-dependent interaction with USP49 in glioblastoma cells. Mol Cancer Res. 2022;20:92\u2013101.","journal-title":"Mol Cancer Res"},{"key":"752_CR38","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.neubiorev.2015.11.009","volume":"61","author":"K Kalafatakis","year":"2016","unstructured":"Kalafatakis K, Russell GM, Zarros A, Lightman SL. Temporal control of glucocorticoid neurodynamics and its relevance for brain homeostasis, neuropathology and glucocorticoid-based therapeutics. Neurosci Biobehav Rev. 2016;61:12\u201325.","journal-title":"Neurosci Biobehav Rev"},{"key":"752_CR39","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.ccell.2024.11.012","volume":"43","author":"MF Gonzalez-Aponte","year":"2025","unstructured":"Gonzalez-Aponte MF, Damato AR, Simon T, Aripova N, Darby F, Jeon MS, Luo J, Rubin JB, Herzog ED. Daily glucocorticoids promote glioblastoma growth and circadian synchrony to the host. Cancer Cell. 2025;43:144\u2013e160147.","journal-title":"Cancer Cell"},{"key":"752_CR40","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.neuron.2023.01.013","volume":"111","author":"RN Curry","year":"2023","unstructured":"Curry RN, Aiba I, Meyer J, Lozzi B, Ko Y, McDonald MF, Rosenbaum A, Cervantes A, Huang-Hobbs E, Cocito C, et al. Glioma epileptiform activity and progression are driven by IGSF3-mediated potassium dysregulation. Neuron. 2023;111:682\u2013e695689.","journal-title":"Neuron"},{"key":"752_CR41","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1016\/j.cell.2022.06.054","volume":"185","author":"V Venkataramani","year":"2022","unstructured":"Venkataramani V, Yang Y, Schubert MC, Reyhan E, Tetzlaff SK, Wi\u00dfmann N, Botz M, Soyka SJ, Beretta CA, Pramatarov RL, et al. Glioblastoma hijacks neuronal mechanisms for brain invasion. Cell. 2022;185:2899\u2013e29172831.","journal-title":"Cell"},{"key":"752_CR42","first-page":"2150","volume":"25","author":"M Ratliff","year":"2023","unstructured":"Ratliff M, Karimian-Jazi K, Hoffmann DC, Rauschenbach L, Simon M, Hai L, Mandelbaum H, Schubert MC, Kessler T, Uhlig S, et al. Individual glioblastoma cells harbor both proliferative and invasive capabilities during tumor progression. Neurooncology. 2023;25:2150\u201362.","journal-title":"Neurooncology"},{"key":"752_CR43","doi-asserted-by":"publisher","first-page":"100565","DOI":"10.1016\/j.modpat.2024.100565","volume":"37","author":"M Massen","year":"2024","unstructured":"Massen M, Thijssen MS, Rademakers G, Idris M, Wouters KAD, van der Meer JRM, Buekers N, Huijgen D, Samarska IV, Weijenberg MP, et al. Neuronal distribution in colorectal cancer: associations with clinicopathological parameters and survival. Mod Pathol. 2024;37:100565.","journal-title":"Mod Pathol"},{"key":"752_CR44","doi-asserted-by":"publisher","first-page":"1236361","DOI":"10.1126\/science.1236361","volume":"341","author":"C Magnon","year":"2013","unstructured":"Magnon C, Hall SJ, Lin J, Xue X, Gerber L, Freedland SJ, Frenette PS. Autonomic nerve development contributes to prostate cancer progression. Science. 2013;341:1236361.","journal-title":"Science"},{"key":"752_CR45","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1111\/1759-7714.12374","volume":"7","author":"JX Shao","year":"2016","unstructured":"Shao JX, Wang B, Yao YN, Pan ZJ, Shen Q, Zhou JY. Autonomic nervous infiltration positively correlates with pathological risk grading and poor prognosis in patients with lung adenocarcinoma. Thorac Cancer. 2016;7:588\u201398.","journal-title":"Thorac Cancer"},{"key":"752_CR46","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.bbe.2017.05.001","volume":"37","author":"MT Makale","year":"2017","unstructured":"Makale MT, Kesari S, Wrasidlo W. The autonomic nervous system and cancer. Biocybern Biomed Eng. 2017;37:443\u201352.","journal-title":"Biocybern Biomed Eng"},{"key":"752_CR47","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1158\/2326-6066.CIR-23-0976","volume":"12","author":"L-Z Shu","year":"2024","unstructured":"Shu L-Z, Ding Y-D, Zhang J-Y, He R-S, Xiao L, Pan B-X, Deng H. Interactions between MDSCs and the autonomic nervous system: opportunities and challenges in cancer neuroscience. Cancer Immunol Res. 2024;12:652\u201362.","journal-title":"Cancer Immunol Res"},{"key":"752_CR48","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00428-024-03873-x","volume":"485","author":"M Kajiwara","year":"2024","unstructured":"Kajiwara M, Takahashi H, Nakaguro M, Kawakita D, Hirai H, Utsumi Y, Urano M, Sato Y, Tsukahara K, Kano S, et al. The clinicopathological and prognostic significance of autonomic nerves in salivary duct carcinoma. Virchows Arch. 2024;485:439\u201352.","journal-title":"Virchows Arch"},{"key":"752_CR49","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41392-020-0205-z","volume":"5","author":"RD Cervantes-Villagrana","year":"2020","unstructured":"Cervantes-Villagrana RD, Albores-Garc\u00eda D, Cervantes-Villagrana AR, Garc\u00eda-Acevez SJ. Tumor-induced neurogenesis and immune evasion as targets of innovative anti-cancer therapies. Signal Transduct Target Therapy. 2020;5:99.","journal-title":"Signal Transduct Target Therapy"},{"key":"752_CR50","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/s41586-019-1219-y","volume":"569","author":"P Mauffrey","year":"2019","unstructured":"Mauffrey P, Tchitchek N, Barroca V, Bemelmans A-P, Firlej V, Allory Y, Rom\u00e9o P-H, Magnon C. Progenitors from the central nervous system drive neurogenesis in cancer. Nature. 2019;569:672\u20138.","journal-title":"Nature"},{"key":"752_CR51","doi-asserted-by":"publisher","first-page":"105325","DOI":"10.1016\/j.ebiom.2024.105325","volume":"108","author":"OV Bj\u00f8rnstad","year":"2024","unstructured":"Bj\u00f8rnstad OV, Carrasco M, Finne K, Ardawatia V, Winge I, Askeland C, Arnes JB, Knutsvik G, Kleftogiannis D, Paulo JA, et al. Global and single-cell proteomics view of the co-evolution between neural progenitors and breast cancer cells in a co-culture model. eBioMedicine. 2024;108:105325.","journal-title":"eBioMedicine"},{"key":"752_CR52","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.devcel.2022.12.011","volume":"58","author":"C Anastasaki","year":"2023","unstructured":"Anastasaki C, Gao Y, Gutmann DH. Neurons as stromal drivers of nervous system cancer formation and progression. Dev Cell. 2023;58:81\u201393.","journal-title":"Dev Cell"},{"key":"752_CR53","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.1002\/ijc.33138","volume":"147","author":"E Jung","year":"2020","unstructured":"Jung E, Alfonso J, Monyer H, Wick W, Winkler F. Neuronal signatures in cancer. Int J Cancer. 2020;147:3281\u201391.","journal-title":"Int J Cancer"},{"key":"752_CR54","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.bpa.2013.10.008","volume":"27","author":"CP Le","year":"2013","unstructured":"Le CP, Karnezis T, Achen MG, Stacker SA, Sloan EK. Lymphovascular and neural regulation of metastasis: shared tumour signalling pathways and novel therapeutic approaches. Best Pract Res Clin Anaesthesiol. 2013;27:409\u201325.","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"752_CR55","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3390\/mps7060099","volume":"7","author":"KC Bauer","year":"2024","unstructured":"Bauer KC, Ghabra S, Ma C, Chedester L, Greten TF. Liver cancer neuroscience: regulating liver tumors via selective hepatic vagotomy. Methods Protocols. 2024;7:99.","journal-title":"Methods Protocols"},{"key":"752_CR56","first-page":"914","volume":"24","author":"K Deshpande","year":"2022","unstructured":"Deshpande K, Martirosian V, Nakamura BN, Iyer M, Julian A, Eisenbarth R, et al. Neuronal exposure induces neurotransmitter signaling and synaptic mediators in tumors early in brain metastasis. Neurooncol. 2022;24:914\u201324.","journal-title":"Neurooncol"},{"key":"752_CR57","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1007\/s12264-023-01082-1","volume":"39","author":"B Ni","year":"2023","unstructured":"Ni B, Yin Y, Li Z, Wang J, Wang X, Wang K. Crosstalk between peripheral innervation and pancreatic ductal adenocarcinoma. Neurosci Bull. 2023;39:1717\u201331.","journal-title":"Neurosci Bull"},{"key":"752_CR58","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s13046-024-03066-z","volume":"43","author":"A G\u00f6hrig","year":"2024","unstructured":"G\u00f6hrig A, Hilfenhaus G, Rosseck F, Welzel M, Moser B, Barbone G, Kunze CA, Rein J, Wilken G, B\u00f6hmig M, et al. Placental growth factor promotes neural invasion and predicts disease prognosis in resectable pancreatic cancer. J Experimental Clin Cancer Res. 2024;43:153.","journal-title":"J Experimental Clin Cancer Res"},{"key":"752_CR59","doi-asserted-by":"publisher","first-page":"6292","DOI":"10.1038\/s41467-022-33991-6","volume":"13","author":"DK Kim","year":"2022","unstructured":"Kim DK, Jeong J, Lee DS, Hyeon DY, Park GW, Jeon S, Lee KB, Jang J-Y, Hwang D, Kim HM, Jung K. PD-L1-directed PlGF\/VEGF Blockade synergizes with chemotherapy by targeting CD141\u2009+\u2009cancer-associated fibroblasts in pancreatic cancer. Nat Commun. 2022;13:6292.","journal-title":"Nat Commun"},{"key":"752_CR60","doi-asserted-by":"publisher","first-page":"4326","DOI":"10.1158\/1078-0432.CCR-13-3426","volume":"20","author":"X Li","year":"2014","unstructured":"Li X, Wang Z, Ma Q, Xu Q, Liu H, Duan W, Lei J, Ma J, Wang X, Lv S, et al. Sonic Hedgehog paracrine signaling activates stromal cells to promote perineural invasion in pancreatic cancer. Clin Cancer Res. 2014;20:4326\u201338.","journal-title":"Clin Cancer Res"},{"key":"752_CR61","doi-asserted-by":"publisher","first-page":"217667","DOI":"10.1016\/j.canlet.2025.217667","volume":"619","author":"Y Wang","year":"2025","unstructured":"Wang Y, Wang Z, Mao X, Zhang H, Zhang L, Yang Y, Liu B, Li X, Luo F, Sun H. Cutting-edge technologies illuminate the neural landscape of cancer: insights into tumor development. Cancer Lett. 2025;619:217667.","journal-title":"Cancer Lett"},{"key":"752_CR62","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13046-018-0674-x","volume":"37","author":"N Kuol","year":"2018","unstructured":"Kuol N, Stojanovska L, Apostolopoulos V, Nurgali K. Role of the nervous system in cancer metastasis. J Experimental Clin Cancer Res. 2018;37:5.","journal-title":"J Experimental Clin Cancer Res"},{"key":"752_CR63","doi-asserted-by":"publisher","first-page":"215610","DOI":"10.1016\/j.canlet.2022.215610","volume":"535","author":"S-H Jiang","year":"2022","unstructured":"Jiang S-H, Zhang S, Wang H, Xue J-L, Zhang Z-G. Emerging experimental models for assessing perineural invasion in human cancers. Cancer Lett. 2022;535:215610.","journal-title":"Cancer Lett"},{"key":"752_CR64","first-page":"309","volume":"26","author":"K Deshpande","year":"2024","unstructured":"Deshpande K, Martirosian V, Nakamura BN, Das D, Iyer M, Reed M, et al. SRRM4-mediated REST to REST4 dysregulation promotes tumor growth and neural adaptation in breast cancer leading to brain metastasis. Neurooncol. 2024;26:309\u201322.","journal-title":"Neurooncol"},{"key":"752_CR65","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1096\/fba.2021-00147","volume":"4","author":"D Li","year":"2022","unstructured":"Li D, Hu LN, Zheng SM, La T, Wei LY, Zhang XJ, Zhang ZH, Xing J, Wang L, Li RQ, et al. High nerve density in breast cancer is associated with poor patient outcome. FASEB BioAdvances. 2022;4:391\u2013401.","journal-title":"FASEB BioAdvances"},{"key":"752_CR66","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1016\/j.molonc.2015.05.001","volume":"9","author":"J Pundavela","year":"2015","unstructured":"Pundavela J, Roselli S, Faulkner S, Attia J, Scott RJ, Thorne RF, Forbes JF, Bradshaw RA, Walker MM, Jobling P, Hondermarck H. Nerve fibers infiltrate the tumor microenvironment and are associated with nerve growth factor production and lymph node invasion in breast cancer. Mol Oncol. 2015;9:1626\u201335.","journal-title":"Mol Oncol"},{"key":"752_CR67","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s13402-023-00901-x","volume":"47","author":"B Han","year":"2023","unstructured":"Han B, Guan X, Ma M, Liang B, Ren L, Liu Y, Du Y, Jiang S-H, Song D. Stiffened tumor microenvironment enhances perineural invasion in breast cancer via integrin signaling. Cell Oncol. 2023;47:867\u201382.","journal-title":"Cell Oncol"},{"key":"752_CR68","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41586-024-07767-5","volume":"633","author":"V Padmanaban","year":"2024","unstructured":"Padmanaban V, Keller I, Seltzer ES, Ostendorf BN, Kerner Z, Tavazoie SF. Neuronal substance P drives metastasis through an extracellular RNA\u2013TLR7 axis. Nature. 2024;633:207\u201315.","journal-title":"Nature"},{"key":"752_CR69","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/nri3545","volume":"13","author":"A Kumanogoh","year":"2013","unstructured":"Kumanogoh A, Kikutani H. Immunological functions of the neuropilins and plexins as receptors for semaphorins. Nat Rev Immunol. 2013;13:802\u201314.","journal-title":"Nat Rev Immunol"},{"key":"752_CR70","doi-asserted-by":"publisher","first-page":"5567","DOI":"10.1038\/onc.2017.165","volume":"36","author":"P Shahi","year":"2017","unstructured":"Shahi P, Wang CY, Chou J, Hagerling C, Gonzalez Velozo H, Ruderisch A, Yu Y, Lai MD, Werb Z. GATA3 targets semaphorin 3B in mammary epithelial cells to suppress breast cancer progression and metastasis. Oncogene. 2017;36:5567\u201375.","journal-title":"Oncogene"},{"key":"752_CR71","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1158\/2159-8290.CD-18-0046","volume":"8","author":"BW Renz","year":"2018","unstructured":"Renz BW, Tanaka T, Sunagawa M, Takahashi R, Jiang Z, Macchini M, Dantes Z, Valenti G, White RA, Middelhoff MA, et al. Cholinergic signaling via muscarinic receptors directly and indirectly suppresses pancreatic tumorigenesis and cancer stemness. Cancer Discov. 2018;8:1458\u201373.","journal-title":"Cancer Discov"},{"key":"752_CR72","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s40478-021-01273-9","volume":"9","author":"PAC Costa","year":"2021","unstructured":"Costa PAC, Silva WN, Prazeres PHDM, Picoli CC, Guardia GDA, Costa AC, Oliveira MA, Guimar\u00e3es PPG, Gon\u00e7alves R, Pinto MCX, et al. Chemogenetic modulation of sensory neurons reveals their regulating role in melanoma progression. Acta Neuropathol Commun. 2021;9:183.","journal-title":"Acta Neuropathol Commun"},{"key":"752_CR73","doi-asserted-by":"publisher","first-page":"5725","DOI":"10.1038\/s41467-021-25967-9","volume":"12","author":"C Liu","year":"2021","unstructured":"Liu C, Yang Y, Chen C, Li L, Li J, Wang X, Chu Q, Qiu L, Ba Q, Li X, Wang H. Environmental eustress modulates \u03b2-ARs\/CCL2 axis to induce anti-tumor immunity and sensitize immunotherapy against liver cancer in mice. Nat Commun. 2021;12:5725.","journal-title":"Nat Commun"},{"key":"752_CR74","doi-asserted-by":"publisher","first-page":"10517","DOI":"10.1038\/ncomms10517","volume":"7","author":"Z Dubeykovskaya","year":"2016","unstructured":"Dubeykovskaya Z, Si Y, Chen X, Worthley DL, Renz BW, Urbanska AM, Hayakawa Y, Xu T, Westphalen CB, Dubeykovskiy A, et al. Neural innervation stimulates Splenic TFF2 to arrest myeloid cell expansion and cancer. Nat Commun. 2016;7:10517.","journal-title":"Nat Commun"},{"key":"752_CR75","first-page":"23","volume":"23","author":"V Venkataramani","year":"2021","unstructured":"Venkataramani V, Tanev DI, Kuner T, Wick W, Winkler F. Synaptic input to brain tumors: clinical implications. Neurooncol. 2021;23:23\u201333.","journal-title":"Neurooncol"},{"key":"752_CR76","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1007\/s13311-022-01320-w","volume":"19","author":"Y Yang","year":"2022","unstructured":"Yang Y, Schubert MC, Kuner T, Wick W, Winkler F, Venkataramani V. Brain tumor networks in diffuse glioma. Neurotherapeutics. 2022;19:1832\u201343.","journal-title":"Neurotherapeutics"},{"key":"752_CR77","doi-asserted-by":"publisher","first-page":"12842","DOI":"10.1074\/jbc.M117.785865","volume":"292","author":"Z Zhang","year":"2017","unstructured":"Zhang Z, Lei A, Xu L, Chen L, Chen Y, Zhang X, Gao Y, Yang X, Zhang M, Cao Y. Similarity in gene-regulatory networks suggests that cancer cells share characteristics of embryonic neural cells. J Biol Chem. 2017;292:12842\u201359.","journal-title":"J Biol Chem"},{"key":"752_CR78","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13578-017-0188-9","volume":"7","author":"Y Cao","year":"2017","unstructured":"Cao Y. Tumorigenesis as a process of gradual loss of original cell identity and gain of properties of neural precursor\/progenitor cells. Cell Bioscience. 2017;7:61.","journal-title":"Cell Bioscience"},{"key":"752_CR79","doi-asserted-by":"publisher","first-page":"101098","DOI":"10.1016\/j.drup.2024.101098","volume":"75","author":"Z Xu","year":"2024","unstructured":"Xu Z, Zhou H, Li T, Yi Q, Thakur A, Zhang K, Ma X, Qin J-J, Yan Y. Application of biomimetic nanovaccines in cancer immunotherapy: A useful strategy to help combat immunotherapy resistance. Drug Resist Updates. 2024;75:101098.","journal-title":"Drug Resist Updates"},{"key":"752_CR80","doi-asserted-by":"publisher","first-page":"107179","DOI":"10.1016\/j.phrs.2024.107179","volume":"203","author":"L Meng","year":"2024","unstructured":"Meng L, Zhang C, Yu P. Treating cancer through modulating Exosomal protein loading and function: the prospects of natural products and traditional Chinese medicine. Pharmacol Res. 2024;203:107179.","journal-title":"Pharmacol Res"},{"key":"752_CR81","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12951-023-01858-7","volume":"21","author":"Z Xu","year":"2023","unstructured":"Xu Z, Xu Y, Zhang K, Liu Y, Liang Q, Thakur A, Liu W, Yan Y. Plant-derived extracellular vesicles (PDEVs) in nanomedicine for human disease and therapeutic modalities. J Nanobiotechnol. 2023;21:114.","journal-title":"J Nanobiotechnol"},{"key":"752_CR82","doi-asserted-by":"publisher","first-page":"106733","DOI":"10.1016\/j.phrs.2023.106733","volume":"190","author":"Q Yi","year":"2023","unstructured":"Yi Q, Xu Z, Thakur A, Zhang K, Liang Q, Liu Y, Yan Y. Current Understanding of plant-derived exosome-like nanoparticles in regulating the inflammatory response and immune system microenvironment. Pharmacol Res. 2023;190:106733.","journal-title":"Pharmacol Res"},{"key":"752_CR83","first-page":"257","volume":"1","author":"J Li","year":"2025","unstructured":"Li J, Peng J, Wang J, Chen Z. The dual role of exosomes in the tumor microenvironment: from pro-tumorigenic signaling to immune modulation. Med Res. 2025;1:257\u201384.","journal-title":"Med Res"},{"key":"752_CR84","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.32604\/or.2024.059113","volume":"33","author":"J Liu","year":"2025","unstructured":"Liu J, Gao F, Wang D, Zhou R, Huang C. Effects and mechanisms of exosomes in microenvironment angiogenesis in breast cancer: an updated review. Oncol Res. 2025;33:1323\u201334.","journal-title":"Oncol Res"},{"key":"752_CR85","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ygyno.2019.04.651","volume":"154","author":"CT Lucido","year":"2019","unstructured":"Lucido CT, Wynja E, Madeo M, Williamson CS, Schwartz LE, Imblum BA, Drapkin R, Vermeer PD. Innervation of cervical carcinoma is mediated by cancer-derived exosomes. Gynecol Oncol. 2019;154:228\u201335.","journal-title":"Gynecol Oncol"},{"key":"752_CR86","doi-asserted-by":"publisher","first-page":"e23803","DOI":"10.1096\/fj.202400625RR","volume":"38","author":"AC Restaino","year":"2024","unstructured":"Restaino AC, Walz A, Barclay SM, Fettig RR, Vermeer PD. Tumor-associated genetic amplifications impact extracellular vesicle MiRNA cargo and their recruitment of nerves in head and neck cancer. FASEB J. 2024;38:e23803.","journal-title":"FASEB J"},{"key":"752_CR87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.32604\/or.2025.070871","volume":"34","author":"W-S Tan","year":"2026","unstructured":"Tan W-S, Kuo H, Jiang C-G, Lu M-H, Lu Y-H, Wang Y-L, Wang C-S, Vo TTT, Lee IT. Salivary biomarkers and their link to oncogenic signaling pathways in oral squamous cell carcinoma: diagnostic and translational perspectives in a narrative review. Oncol Res. 2026;34:1\u201310.","journal-title":"Oncol Res"},{"key":"752_CR88","doi-asserted-by":"publisher","first-page":"216689","DOI":"10.1016\/j.canlet.2024.216689","volume":"587","author":"Z Cai","year":"2024","unstructured":"Cai Z, Yao H, Chen J, Ahmed AA, Li C, Hu X, Tang X, Jiang C. Schwann cells in pancreatic cancer: unraveling their multifaceted roles in tumorigenesis and neural interactions. Cancer Lett. 2024;587:216689.","journal-title":"Cancer Lett"},{"key":"752_CR89","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/s41586-020-1996-3","volume":"578","author":"M Amit","year":"2020","unstructured":"Amit M, Takahashi H, Dragomir MP, Lindemann A, Gleber-Netto FO, Pickering CR, Anfossi S, Osman AA, Cai Y, Wang R, et al. Loss of p53 drives neuron reprogramming in head and neck cancer. Nature. 2020;578:449\u201354.","journal-title":"Nature"},{"key":"752_CR90","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.cell.2024.11.002","volume":"188","author":"SK Tetzlaff","year":"2025","unstructured":"Tetzlaff SK, Reyhan E, Layer N, Bengtson CP, Heuer A, Schroers J, Faymonville AJ, Langeroudi AP, Drewa N, Keifert E, et al. Characterizing and targeting glioblastoma neuron-tumor networks with retrograde tracing. Cell. 2025;188:390\u2013e411336.","journal-title":"Cell"},{"key":"752_CR91","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s12015-024-10809-0","volume":"21","author":"MBA Djamgoz","year":"2024","unstructured":"Djamgoz MBA. Stemness of cancer: a study of Triple-negative breast cancer from a neuroscience perspective. Stem Cell Rev Rep. 2024;21:337\u201350.","journal-title":"Stem Cell Rev Rep"},{"key":"752_CR92","doi-asserted-by":"publisher","first-page":"100351","DOI":"10.1016\/j.bbih.2021.100351","volume":"18","author":"JC Borniger","year":"2021","unstructured":"Borniger JC. Cancer as a tool for preclinical psychoneuroimmunology. Brain Behav Immun - Health. 2021;18:100351.","journal-title":"Brain Behav Immun - Health"},{"key":"752_CR93","first-page":"454","volume":"33","author":"AMH Rend\u00f3n","year":"2025","unstructured":"Rend\u00f3n AMH, Medina Medina A, Gonz\u00e1lez CP, Gomez JJV, Limonero JT, Krikorian A. The relationship between suffering, loneliness, social interaction, and perceived symptoms in advanced cancer patients. Support Care Cancer. 2025;33:454.","journal-title":"Support Care Cancer"},{"key":"752_CR94","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1093\/jnci\/djab027","volume":"113","author":"AM Henneghan","year":"2021","unstructured":"Henneghan AM, Van Dyk K, Kaufmann T, Harrison R, Gibbons C, Heijnen C, Kesler SR. Measuring Self-Reported cancer-Related cognitive impairment: recommendations from the cancer neuroscience initiative working group. JNCI: J Natl Cancer Inst. 2021;113:1625\u201333.","journal-title":"JNCI: J Natl Cancer Inst"},{"key":"752_CR95","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3390\/cancers17010139","volume":"17","author":"F Siddi","year":"2025","unstructured":"Siddi F, Emedom-Nnamdi P, Catalino MP, Rana A, Boaro A, Dawood HY, Sala F, Onnela J-P, Smith TR. A digital phenotypic assessment in Neuro-Oncology (DANO): A pilot study on sociability changes in patients undergoing treatment for brain malignancies. Cancers. 2025;17:139.","journal-title":"Cancers"},{"key":"752_CR96","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.bbi.2024.10.005","volume":"123","author":"E Trachtenberg","year":"2025","unstructured":"Trachtenberg E, Ruzal K, Sandbank E, Bigelman E, Ricon-Becker I, Cole SW, Ben-Eliyahu S, Ben-Ami Bartal I. Deleterious effects of social isolation on neuroendocrine-immune status, and cancer progression in rats. Brain Behav Immun. 2025;123:524\u201339.","journal-title":"Brain Behav Immun"},{"key":"752_CR97","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.3390\/jpm14111108","volume":"14","author":"J Valerio","year":"2024","unstructured":"Valerio J, Borro M, Santiago Rea N, Valente L, Fernandez-Gomez MP, Zumaeta J, Mantilla P, Alvarez-Pinzon AM. Radiosurgery for hypothalamic gliomas: A case report and clinical guidelines form a neurosurgical center of excellence. J Personalized Med. 2024;14:1108.","journal-title":"J Personalized Med"},{"key":"752_CR98","doi-asserted-by":"publisher","first-page":"136861","DOI":"10.1016\/j.neulet.2022.136861","volume":"790","author":"S Savchuk","year":"2022","unstructured":"Savchuk S, Monje M. Mini-review: aplastic Myelin following chemotherapy. Neurosci Lett. 2022;790:136861.","journal-title":"Neurosci Lett"},{"key":"752_CR99","doi-asserted-by":"publisher","first-page":"1408306","DOI":"10.3389\/fnins.2024.1408306","volume":"18","author":"X Ma","year":"2024","unstructured":"Ma X, Deng K, Sun Y, Wu M. Research trends on cancer neuroscience: a bibliometric and visualized analysis. Front NeuroSci. 2024;18:1408306.","journal-title":"Front NeuroSci"},{"key":"752_CR100","doi-asserted-by":"publisher","first-page":"6237","DOI":"10.3390\/ijms25116237","volume":"25","author":"SK Mandal","year":"2024","unstructured":"Mandal SK, Yadav P, Sheth RA. The neuroimmune axis and its therapeutic potential for primary liver cancer. Int J Mol Sci. 2024;25:6237.","journal-title":"Int J Mol Sci"},{"key":"752_CR101","doi-asserted-by":"publisher","first-page":"218070","DOI":"10.1016\/j.canlet.2025.218070","volume":"634","author":"F Vanden Abeele","year":"2025","unstructured":"Vanden Abeele F, Salzet M. The neuro-immune oncology axis. Cancer Lett. 2025;634:218070.","journal-title":"Cancer Lett"},{"key":"752_CR102","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1158\/2159-8290.CD-23-0397","volume":"15","author":"PD Vermeer","year":"2025","unstructured":"Vermeer PD, Restaino AC, Barr JL, Yaniv D, Amit M. Nerves at play: the peripheral nervous system in extracranial malignancies. Cancer Discov. 2025;15:52\u201368.","journal-title":"Cancer Discov"},{"key":"752_CR103","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13045-025-01748-5","volume":"18","author":"C Zhang","year":"2025","unstructured":"Zhang C, Guo X, Liu P, Wang Y, Zhang J, Li L, Wu K, Xiao J, Mei Q, Wang Z. The neuro-immune axis in cancer: from mechanisms to therapeutic opportunities. J Hematol Oncol. 2025;18:93.","journal-title":"J Hematol Oncol"},{"key":"752_CR104","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.3390\/cancers16223877","volume":"16","author":"V Durmanova","year":"2024","unstructured":"Durmanova V, Mikolaskova I, Zsemlye E, Ocenasova A, Bandzuchova H, Suchankova M, Kollarik B, Palacka P, Zvarik M, Bucova M, Hunakova L. Association of HLA-G Expression, its genetic variants and related Neuro-Immunomodulation with characteristics of bladder carcinoma. Cancers. 2024;16:3877.","journal-title":"Cancers"},{"key":"752_CR105","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/diseases11010009","volume":"11","author":"H Hu","year":"2023","unstructured":"Hu H, Chen Q, Zheng S, Du S, Ding S, Lun Y. Transcriptome analysis revealed potential Neuro-Immune interaction in papillary thyroid carcinoma tissues. Diseases. 2023;11:9.","journal-title":"Diseases"},{"key":"752_CR106","doi-asserted-by":"publisher","first-page":"3541","DOI":"10.3390\/cells11223541","volume":"11","author":"GV Shurin","year":"2022","unstructured":"Shurin GV, Vats K, Kruglov O, Bunimovich YL, Shurin MR. Tumor-induced T cell polarization by Schwann cells. Cells. 2022;11:3541.","journal-title":"Cells"},{"key":"752_CR107","doi-asserted-by":"publisher","first-page":"e2200122","DOI":"10.1002\/adbi.202200122","volume":"6","author":"Y Pan","year":"2022","unstructured":"Pan Y, Monje M. Neuron\u2013Glial interactions in health and brain cancer. Adv Biology. 2022;6:e2200122.","journal-title":"Adv Biology"},{"key":"752_CR108","doi-asserted-by":"publisher","first-page":"1528363","DOI":"10.3389\/fimmu.2025.1528363","volume":"16","author":"J Wen","year":"2025","unstructured":"Wen J, Li Y, Deng W, Li Z. Central nervous system and immune cells interactions in cancer: unveiling new therapeutic avenues. Front Immunol. 2025;16:1528363.","journal-title":"Front Immunol"},{"key":"752_CR109","doi-asserted-by":"publisher","first-page":"100859","DOI":"10.1016\/j.bbih.2024.100859","volume":"42","author":"S Brem","year":"2024","unstructured":"Brem S. Vagus nerve stimulation: novel concept for the treatment of glioblastoma and solid cancers by cytokine (interleukin-6) reduction, attenuating the SASP, enhancing tumor immunity. Brain Behav Immun - Health. 2024;42:100859.","journal-title":"Brain Behav Immun - Health"},{"key":"752_CR110","doi-asserted-by":"publisher","first-page":"e784","DOI":"10.1002\/mco2.784","volume":"5","author":"HY Fan","year":"2024","unstructured":"Fan HY, Liang XH, Tang YL. Neuroscience in peripheral cancers: tumors hijacking nerves and neuroimmune crosstalk. MedComm. 2024;5:e784.","journal-title":"MedComm"},{"key":"752_CR111","doi-asserted-by":"publisher","first-page":"983","DOI":"10.3390\/biom13060983","volume":"13","author":"N Erin","year":"2023","unstructured":"Erin N, Szallasi A. Carcinogenesis and metastasis: focus on TRPV1-positive neurons and immune cells. Biomolecules. 2023;13:983.","journal-title":"Biomolecules"},{"key":"752_CR112","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12929-024-01083-w","volume":"31","author":"M-H Ho","year":"2024","unstructured":"Ho M-H, Tsai Y-J, Chen C-Y, Yang A, Burnouf T, Wang Y, Chiang Y-H, Hoffer BJ, Chou S-Y. CCL5 is essential for axonogenesis and neuronal restoration after brain injury. J Biomed Sci. 2024;31:91.","journal-title":"J Biomed Sci"},{"key":"752_CR113","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/cns.14006","volume":"29","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Li Y, Jiang S, Shi FD, Shi K, Jin WN. Targeting CCL5 signaling attenuates neuroinflammation after seizure. CNS Neurosci Ther. 2022;29:317\u201330.","journal-title":"CNS Neurosci Ther"},{"key":"752_CR114","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.3390\/brainsci13101424","volume":"13","author":"K Irshad","year":"2023","unstructured":"Irshad K, Huang Y-K, Rodriguez P, Lo J, Aghoghovwia BE, Pan Y, Chang K-C. The neuroimmune regulation and potential therapeutic strategies of optic pathway glioma. Brain Sci. 2023;13:1424.","journal-title":"Brain Sci"},{"key":"752_CR115","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1158\/0008-5472.CAN-19-2689","volume":"80","author":"M-W Yang","year":"2020","unstructured":"Yang M-W, Tao L-Y, Jiang Y-S, Yang J-Y, Huo Y-M, Liu D-J, Li J, Fu X-L, He R, Lin C, et al. Perineural invasion reprograms the immune microenvironment through cholinergic signaling in pancreatic ductal adenocarcinoma. Cancer Res. 2020;80:1991\u20132003.","journal-title":"Cancer Res"},{"key":"752_CR116","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41422-025-01098-4","volume":"35","author":"K Wang","year":"2025","unstructured":"Wang K, Ni B, Xie Y, Li Z, Yuan L, Meng C, Zhao T, Gao S, Huang C, Wang H, et al. Nociceptor neurons promote PDAC progression and cancer pain by interaction with cancer-associated fibroblasts and suppression of natural killer cells. Cell Res. 2025;35:362\u201380.","journal-title":"Cell Res."},{"key":"752_CR117","doi-asserted-by":"publisher","first-page":"120305","DOI":"10.1016\/j.lfs.2022.120305","volume":"291","author":"N Erin","year":"2022","unstructured":"Erin N, Akman M, Aliyev E, Tanr\u0131\u00f6ver G, Korcum AF. Olvanil activates sensory nerve fibers, increases T cell response and decreases metastasis of breast carcinoma. Life Sci. 2022;291:120305.","journal-title":"Life Sci"},{"key":"752_CR118","doi-asserted-by":"publisher","first-page":"4670","DOI":"10.1111\/febs.17280","volume":"291","author":"B Kizil","year":"2024","unstructured":"Kizil B, De Virgiliis F, Scheiermann C. Neural control of tumor immunity. FEBS J. 2024;291:4670\u20139.","journal-title":"FEBS J"},{"key":"752_CR119","doi-asserted-by":"publisher","first-page":"101212","DOI":"10.1016\/j.drup.2025.101212","volume":"79","author":"G Li","year":"2025","unstructured":"Li G, Jiang Y, Tong H, Liu J, Jiang Z, Zhao Y, Tan K, Zhang Y, Yin X, Yun H, et al. Sciatic nerve stimulation enhances NK cell cytotoxicity through dopamine signaling and synergizes immunotherapy in triple-negative breast cancer. Drug Resist Updates. 2025;79:101212.","journal-title":"Drug Resist Updates"},{"key":"752_CR120","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.bbi.2015.02.024","volume":"48","author":"N Erin","year":"2015","unstructured":"Erin N, Korcum AF, Tanr\u0131\u00f6ver G, Kale \u015e, Demir N, K\u00f6ksoy S. Activation of neuroimmune pathways increases therapeutic effects of radiotherapy on poorly differentiated breast carcinoma. Brain Behav Immun. 2015;48:174\u201385.","journal-title":"Brain Behav Immun"},{"key":"752_CR121","doi-asserted-by":"publisher","first-page":"5555","DOI":"10.1038\/s41467-024-49824-7","volume":"15","author":"Y Hou","year":"2024","unstructured":"Hou Y, Lin B, Xu T, Jiang J, Luo S, Chen W, Chen X, Wang Y, Liao G, Wang J, et al. The neurotransmitter calcitonin gene-related peptide shapes an immunosuppressive microenvironment in medullary thyroid cancer. Nat Commun. 2024;15:5555.","journal-title":"Nat Commun"},{"key":"752_CR122","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.trecan.2023.05.002","volume":"9","author":"N Khanmammadova","year":"2023","unstructured":"Khanmammadova N, Islam S, Sharma P, Amit M. Neuro-immune interactions and immuno-oncology. Trends Cancer. 2023;9:636\u201349.","journal-title":"Trends Cancer"},{"key":"752_CR123","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1186\/s40001-024-02224-5","volume":"29","author":"Y Wang","year":"2024","unstructured":"Wang Y, Bai M, Peng Q, Li L, Tian F, Guo Y, Jing C. Angiogenesis, a key point in the association of gut microbiota and its metabolites with disease. Eur J Med Res. 2024;29:614.","journal-title":"Eur J Med Res"},{"key":"752_CR124","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1186\/s40001-024-02168-w","volume":"29","author":"A Bahrami","year":"2024","unstructured":"Bahrami A, Khalaji A, Bahri Najafi M, Sadati S, Raisi A, Abolhassani A, Eshraghi R, Khaksary Mahabady M, Rahimian N, Mirzaei H. NF-\u03baB pathway and angiogenesis: insights into colorectal cancer development and therapeutic targets. Eur J Med Res. 2024;29:610.","journal-title":"Eur J Med Res"},{"key":"752_CR125","doi-asserted-by":"publisher","first-page":"101419","DOI":"10.1016\/j.mtbio.2024.101419","volume":"30","author":"J-X Huang","year":"2025","unstructured":"Huang J-X, Yang R, Long H, Kong J, Shao G-Q, Xiong F. Dual-drug loaded chondroitin sulfate embolization beads enhance TACE therapy for HCC by integrating embolization, chemotherapy, and anti-angiogenesis. Mater Today Bio. 2025;30:101419.","journal-title":"Mater Today Bio"},{"key":"752_CR126","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.32604\/or.2025.060440","volume":"33","author":"G-Z Xu","year":"2025","unstructured":"Xu G-Z, Guan H-Y, Guo Y-G, Zhang Y-R, Pan J-H, Luo S, et al. USP13 suppresses colorectal cancer angiogenesis by downregulating VEGFA expression through inhibition of the PTEN-AKT pathway. Oncol Res. 2025;33:1947\u201367.","journal-title":"Oncol Res"},{"key":"752_CR127","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.cpan.2025.02.001","volume":"21","author":"R Bolleddu","year":"2025","unstructured":"Bolleddu R, Mangal AK, Abdullah S, Narasimhaji GB, Nagayya CV, Srikanth SGN. The role of ursolic acid, a pharmacologically active compound from ocimum sanctum L. as a potential chemotherapeutic agent. Curr Pharm Anal. 2025;21:77\u201387.","journal-title":"Curr Pharm Anal"},{"key":"752_CR128","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12307-018-0207-3","volume":"11","author":"N Kuol","year":"2018","unstructured":"Kuol N, Stojanovska L, Apostolopoulos V, Nurgali K. Role of the nervous system in tumor angiogenesis. Cancer Microenviron. 2018;11:1\u201311.","journal-title":"Cancer Microenviron"},{"key":"752_CR129","first-page":"1","volume":"00","author":"M Tang","year":"2025","unstructured":"Tang M, Mo Y, Ling Z, Zeng Y, Zhang Q, Zheng S, Wen S, Xiao Y, Long S, Yang T, et al. Non-Histone lactylation: A new frontier in cerebral Ischemia\u2010Reperfusion injury. Med Res. 2025;00:1\u201318.","journal-title":"Med Res"},{"key":"752_CR130","doi-asserted-by":"publisher","first-page":"1284629","DOI":"10.3389\/fimmu.2024.1284629","volume":"15","author":"S Shalabi","year":"2024","unstructured":"Shalabi S, Belayachi A, Larriv\u00e9e B. Involvement of neuronal factors in tumor angiogenesis and the shaping of the cancer microenvironment. Front Immunol. 2024;15:1284629.","journal-title":"Front Immunol"},{"key":"752_CR131","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/nature04481","volume":"438","author":"DA Greenberg","year":"2005","unstructured":"Greenberg DA, Jin K. From angiogenesis to neuropathology. Nature. 2005;438:954\u20139.","journal-title":"Nature"},{"key":"752_CR132","unstructured":"Wik E, Aziz S, Finne K, Kleftogiannis D, Askeland C, Knutsvik G, Kr\u00fcger K, Svan\u00f8e AA, Birkeland E, Kj\u00f8lle S et al. Single-cell mapping links neurogenesis and angiogenesis in aggressive breast cancer. bioRxiv; 2024."},{"key":"752_CR133","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1097\/j.pain.0000000000002970","volume":"164","author":"K Gomez","year":"2023","unstructured":"Gomez K, Duran P, Tonello R, Allen HN, Boinon L, Calderon-Rivera A, Loya-L\u00f3pez S, Nelson TS, Ran D, Moutal A, et al. Neuropilin-1 is essential for vascular endothelial growth factor A\u2013mediated increase of sensory neuron activity and development of pain-like behaviors. Pain. 2023;164:2696\u2013710.","journal-title":"Pain"},{"key":"752_CR134","first-page":"1462","volume":"20","author":"SR Michaelsen","year":"2018","unstructured":"Michaelsen SR, Staberg M, Pedersen H, Jensen KE, Majewski W, Broholm H, Nedergaard MK, Meulengracht C, Urup T, Villingsh\u00f8j M, et al. VEGF-C sustains VEGFR2 activation under bevacizumab therapy and promotes glioblastoma maintenance. Neurooncology. 2018;20:1462\u201374.","journal-title":"Neurooncology"},{"key":"752_CR135","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1084\/jem.20111424","volume":"209","author":"P Hamerlik","year":"2012","unstructured":"Hamerlik P, Lathia JD, Rasmussen R, Wu Q, Bartkova J, Lee M, Moudry P, Bartek J, Fischer W, Lukas J, et al. Autocrine VEGF\u2013VEGFR2\u2013Neuropilin-1 signaling promotes glioma stem-like cell viability and tumor growth. J Exp Med. 2012;209:507\u201320.","journal-title":"J Exp Med"},{"key":"752_CR136","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1038\/nm905","volume":"9","author":"RG Fahmy","year":"2003","unstructured":"Fahmy RG, Dass CR, Sun L-Q, Chesterman CN, Khachigian LM. Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth. Nat Med. 2003;9:1026\u201332.","journal-title":"Nat Med"},{"key":"752_CR137","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41421-023-00521-7","volume":"9","author":"J Yu","year":"2023","unstructured":"Yu J, Zhuang A, Gu X, Hua Y, Yang L, Ge S, Ruan J, Chai P, Jia R, Fan X. Nuclear PD-L1 promotes EGR1-mediated angiogenesis and accelerates tumorigenesis. Cell Discovery. 2023;9:33.","journal-title":"Cell Discovery"},{"key":"752_CR138","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0166-2236(98)01343-5","volume":"22","author":"KJ O\u2019Donovan","year":"1999","unstructured":"O\u2019Donovan KJ, Tourtellotte WG, Millbrandt J, Baraban JM. The EGR family of transcription-regulatory factors: progress at the interface of molecular and systems neuroscience. Trends Neurosci. 1999;22:167\u201373.","journal-title":"Trends Neurosci"},{"key":"752_CR139","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1016\/j.ccell.2023.07.010","volume":"41","author":"A Sanchez-Aguilera","year":"2023","unstructured":"Sanchez-Aguilera A, Masmudi-Mart\u00edn M, Navas-Olive A, Baena P, Hern\u00e1ndez-Oliver C, Priego N, Cord\u00f3n-Barris L, Alvaro-Espinosa L, Garc\u00eda S, Mart\u00ednez S, et al. Machine learning identifies experimental brain metastasis subtypes based on their influence on neural circuits. Cancer Cell. 2023;41:1637\u2013e16491611.","journal-title":"Cancer Cell"},{"key":"752_CR140","doi-asserted-by":"publisher","first-page":"e2101837","DOI":"10.1002\/advs.202101837","volume":"8","author":"I Elorza Ridaura","year":"2021","unstructured":"Elorza Ridaura I, Sorrentino S, Moroni L. Parallels between the developing vascular and neural systems: signaling pathways and future perspectives for regenerative medicine. Adv Sci. 2021;8:e2101837.","journal-title":"Adv Sci"},{"key":"752_CR141","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12964-023-01159-4","volume":"21","author":"L Isosaari","year":"2023","unstructured":"Isosaari L, Vuorenp\u00e4\u00e4 H, Yrj\u00e4n\u00e4inen A, Kapucu FE, Kelloniemi M, Pakarinen T-K, Miettinen S, Narkilahti S. Simultaneous induction of vasculature and neuronal network formation on a chip reveals a dynamic interrelationship between cell types. Cell Communication Signal. 2023;21:132.","journal-title":"Cell Communication Signal"},{"key":"752_CR142","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1002\/glia.24391","volume":"71","author":"W Zhang Wj","year":"2023","unstructured":"Zhang Wj W, Cl L, Jp. Schwann cells as a target cell for the treatment of cancer pain. Glia. 2023;71:2309\u201322.","journal-title":"Glia"},{"key":"752_CR143","doi-asserted-by":"publisher","first-page":"217399","DOI":"10.1016\/j.canlet.2024.217399","volume":"611","author":"R Zhang","year":"2025","unstructured":"Zhang R, Yang Y, Li X, Jiao C, Lou M, Mi W, Mao-Ying Q-L, Chu Y, Wang Y. Exploring shared targets in cancer immunotherapy and cancer-induced bone pain: insights from preclinical studies. Cancer Lett. 2025;611:217399.","journal-title":"Cancer Lett"},{"key":"752_CR144","doi-asserted-by":"publisher","first-page":"101254","DOI":"10.1016\/j.blre.2024.101254","volume":"69","author":"D Kegyes","year":"2025","unstructured":"Kegyes D, Moisoiu V, Constantinescu C, Tanase A, Ghiaur G, Einsele H, Tomuleasa C, Lazarus HM, Gale RP. Neuro-toxicities of chemo- and immune-therapies in haematologic malignancies: from mechanism to management. Blood Rev. 2025;69:101254.","journal-title":"Blood Rev"},{"key":"752_CR145","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.tins.2024.11.008","volume":"48","author":"L Jiang","year":"2025","unstructured":"Jiang L, Cai S, Weng Z, Zhang S, Jiang S-H. Peripheral, central, and chemotherapy-induced neuropathic changes in pancreatic cancer. Trends Neurosci. 2025;48:124\u201339.","journal-title":"Trends Neurosci"},{"key":"752_CR146","doi-asserted-by":"publisher","first-page":"991","DOI":"10.3390\/life14080991","volume":"14","author":"M Mattar","year":"2024","unstructured":"Mattar M, Umutoni F, Hassan MA, Wamburu MW, Turner R, Patton JS, Chen X, Lei W. Chemotherapy-induced peripheral neuropathy: a recent update on pathophysiology and treatment. Life. 2024;14:991.","journal-title":"Life"},{"key":"752_CR147","doi-asserted-by":"publisher","first-page":"217433","DOI":"10.1016\/j.canlet.2024.217433","volume":"611","author":"Z Tao","year":"2025","unstructured":"Tao Z, Chen Z, Zeng X, Cui J, Quan M. An emerging aspect of cancer neuroscience: a literature review on chemotherapy-induced peripheral neuropathy. Cancer Lett. 2025;611:217433.","journal-title":"Cancer Lett"},{"key":"752_CR148","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s44303-024-00054-y","volume":"2","author":"C Butler-Hallissey","year":"2024","unstructured":"Butler-Hallissey C, Leterrier C. Super-resolution imaging of the neuronal cytoskeleton. Npj Imaging. 2024;2:50.","journal-title":"Npj Imaging"},{"key":"752_CR149","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.3390\/ijms20092287","volume":"20","author":"A Malacrida","year":"2019","unstructured":"Malacrida A, Meregalli C, Rodriguez-Menendez V, Nicolini G. Chemotherapy-Induced peripheral neuropathy and changes in cytoskeleton. Int J Mol Sci. 2019;20:2287.","journal-title":"Int J Mol Sci"},{"key":"752_CR150","doi-asserted-by":"publisher","first-page":"114258","DOI":"10.1016\/j.expneurol.2022.114258","volume":"359","author":"GJ-e Shin","year":"2023","unstructured":"Shin GJ-e. Towards a mechanistic Understanding of axon transport and endocytic changes underlying paclitaxel-induced peripheral neuropathy. Exp Neurol. 2023;359:114258.","journal-title":"Exp Neurol"},{"key":"752_CR151","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1091\/mbc.e14-04-0916","volume":"25","author":"BA Weaver","year":"2014","unstructured":"Weaver BA, Bement W. How taxol\/paclitaxel kills cancer cells. Mol Biol Cell. 2014;25:2677\u201381.","journal-title":"Mol Biol Cell"},{"key":"752_CR152","doi-asserted-by":"publisher","first-page":"174480691987808","DOI":"10.1177\/1744806919878088","volume":"15","author":"KM Kober","year":"2019","unstructured":"Kober KM, Schumacher M, Conley YP, Topp K, Mazor M, Hammer MJ, Paul SM, Levine JD, Miaskowski C. Signaling pathways and gene co-expression modules associated with cytoskeleton and axon morphology in breast cancer survivors with chronic paclitaxel-induced peripheral neuropathy. Mol Pain. 2019;15:1744806919878088.","journal-title":"Mol Pain"},{"key":"752_CR153","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3344\/kjp.24358","volume":"38","author":"SJ Park","year":"2025","unstructured":"Park SJ, Lee S-M, Kang SM, Yang H-M, Seo S-K, Lee J-H. Potential of histone deacetylase 6 inhibitors in alleviating chemotherapy-induced peripheral neuropathy. Korean J Pain. 2025;38:152\u201362.","journal-title":"Korean J Pain"},{"key":"752_CR154","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1136\/spcare-2022-003815","volume":"13","author":"R Chow","year":"2023","unstructured":"Chow R, Novosel M, So OW, Bellampalli S, Xiang J, Boldt G, et al. Duloxetine for prevention and treatment of chemotherapy-induced peripheral neuropathy (CIPN): systematic review and meta-analysis. BMJ Support Palliat Care. 2023;13:27\u201334.","journal-title":"BMJ Support Palliat Care"},{"key":"752_CR155","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1080\/17581869.2025.2494495","volume":"15","author":"M Belayneh","year":"2025","unstructured":"Belayneh M, Hejazi S, Gagnon B, Hawley P. Methadone to treat chemotherapy-induced peripheral neuropathy (METACIN): study protocol. Pain Manage. 2025;15:235\u201343.","journal-title":"Pain Manage"},{"key":"752_CR156","first-page":"493","volume":"32","author":"M Aghili","year":"2024","unstructured":"Aghili M, Taherioun M, Jafari F, Azadvari M, Lashkari M, Kolahdouzan K, Ghalehtaki R, Abdshah A. Duloxetine to prevent neuropathy in breast cancer patients under Paclitaxel chemotherapy (a double-blind randomized trial). Support Care Cancer. 2024;32:493.","journal-title":"Support Care Cancer"},{"key":"752_CR157","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1186\/s13063-018-2874-2","volume":"19","author":"MS Jang Ce, Jung","year":"2018","unstructured":"Jang Ce, Jung MS, Sohn EH, Kim M, Yoo H-S, Bae K, Kim JR, Lee JS. The evaluation of changes in peripheral neuropathy and quality-of-life using low-frequency electrostimulation in patients treated with chemotherapy for breast cancer: a study protocol. Trials. 2018;19:526.","journal-title":"Trials"},{"key":"752_CR158","doi-asserted-by":"publisher","first-page":"153473542092551","DOI":"10.1177\/1534735420925519","volume":"19","author":"S-Y Song","year":"2020","unstructured":"Song S-Y, Park J-H, Lee JS, Kim JR, Sohn EH, Jung MS, Yoo H-S. A randomized, placebo-controlled trial evaluating changes in peripheral neuropathy and quality of life by using low-frequency electrostimulation on breast cancer patients treated with chemotherapy. Integr Cancer Ther. 2020;19:1534735420925519.","journal-title":"Integr Cancer Ther"},{"key":"752_CR159","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.resinv.2024.07.017","volume":"62","author":"N Nakamura","year":"2024","unstructured":"Nakamura N, Makimoto G, Tanaka T, Kato Y, Oze I, Kozuki T, Yokoyama T, Ichikawa H, Kuyama S, Hara N, et al. A randomized, open-label phase II study on the preventive effect of Goshajinkigan against peripheral neuropathy induced by paclitaxel-containing chemotherapy: the OLCSG2101 study protocol. Respiratory Invest. 2024;62:897\u2013900.","journal-title":"Respiratory Invest"},{"key":"752_CR160","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/S1474-4422(24)00160-1","volume":"23","author":"A Salvalaggio","year":"2024","unstructured":"Salvalaggio A, Pini L, Bertoldo A, Corbetta M. Glioblastoma and brain connectivity: the need for a paradigm shift. Lancet Neurol. 2024;23:740\u20138.","journal-title":"Lancet Neurol"},{"key":"752_CR161","doi-asserted-by":"publisher","first-page":"e431","DOI":"10.1002\/mco2.431","volume":"4","author":"YL Lan","year":"2023","unstructured":"Lan YL, Zou S, Wang W, Chen Q, Zhu Y. Progress in cancer neuroscience. MedComm. 2023;4:e431.","journal-title":"MedComm"},{"key":"752_CR162","doi-asserted-by":"publisher","first-page":"117957352412921","DOI":"10.1177\/11795735241292188","volume":"16","author":"L Zhang","year":"2024","unstructured":"Zhang L, Wang Y, Cai X, Mao X, Sun H. Deciphering the CNS-glioma dialogue: advanced insights into CNS-glioma communication pathways and their therapeutic potential. J Cent Nerv Syst Disease. 2024;16:11795735241292188.","journal-title":"J Cent Nerv Syst Disease"},{"key":"752_CR163","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41578-024-00681-2","volume":"9","author":"JD Bernstock","year":"2024","unstructured":"Bernstock JD, Johnston BR, Friedman GK, Chiocca EA, Langer R, Srinivasan SS. Leveraging next-generation materials for cancer neuroscience therapies in the central nervous system. Nat Rev Mater. 2024;9:298\u2013300.","journal-title":"Nat Rev Mater"},{"key":"752_CR164","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.3390\/cells11081294","volume":"11","author":"Y Guo","year":"2022","unstructured":"Guo Y, Gil Z. The role of extracellular vesicles in cancer\u2013nerve crosstalk of the peripheral nervous system. Cells. 2022;11:1294.","journal-title":"Cells"},{"key":"752_CR165","doi-asserted-by":"publisher","first-page":"108750","DOI":"10.1016\/j.pharmthera.2024.108750","volume":"264","author":"Z-K Dong","year":"2024","unstructured":"Dong Z-K, Wang Y-F, Li W-P, Jin W-L. Neurobiology of cancer: adrenergic signaling and drug repurposing. Pharmacol Ther. 2024;264:108750.","journal-title":"Pharmacol Ther"},{"key":"752_CR166","doi-asserted-by":"publisher","first-page":"990665","DOI":"10.3389\/fphar.2022.990665","volume":"13","author":"J Shi","year":"2022","unstructured":"Shi J, Xu J, Li Y, Li B, Ming H, Nice EC, Huang C, Li Q, Wang C. Drug repurposing in cancer neuroscience: from the viewpoint of the autophagy-mediated innervated niche. Front Pharmacol. 2022;13:990665.","journal-title":"Front Pharmacol"},{"key":"752_CR167","doi-asserted-by":"publisher","first-page":"e62","DOI":"10.1016\/S1470-2045(21)00596-9","volume":"23","author":"DD Shi","year":"2022","unstructured":"Shi DD, Guo JA, Hoffman HI, Su J, Mino-Kenudson M, Barth JL, Schenkel JM, Loeffler JS, Shih HA, Hong TS, et al. Therapeutic avenues for cancer neuroscience: translational frontiers and clinical opportunities. Lancet Oncol. 2022;23:e62\u201374.","journal-title":"Lancet Oncol"},{"key":"752_CR168","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.trecan.2024.09.003","volume":"10","author":"CN Gonzales","year":"2024","unstructured":"Gonzales CN, Negussie MB, Krishna S, Ambati VS, Hervey-Jumper SL. Malignant glioma remodeling of neuronal circuits: therapeutic opportunities and repurposing of antiepileptic drugs. Trends Cancer. 2024;10:1106\u201315.","journal-title":"Trends Cancer"},{"key":"752_CR169","doi-asserted-by":"publisher","first-page":"582","DOI":"10.3390\/biomedicines11020582","volume":"11","author":"M Stella","year":"2023","unstructured":"Stella M, Baiardi G, Pasquariello S, Sacco F, Dellacasagrande I, Corsaro A, Mattioli F, Barbieri F. Antitumor potential of antiepileptic drugs in human glioblastoma: pharmacological targets and clinical benefits. Biomedicines. 2023;11:582.","journal-title":"Biomedicines"},{"key":"752_CR170","doi-asserted-by":"publisher","first-page":"14695","DOI":"10.3390\/ijms232314695","volume":"23","author":"M Arese","year":"2022","unstructured":"Arese M, Bussolino F, Pergolizzi M, Bizzozero L. An overview of the molecular cues and their intracellular signaling shared by cancer and the nervous system: from neurotransmitters to synaptic Proteins, anatomy of an All-Inclusive Cooperation. Int J Mol Sci. 2022;23:14695.","journal-title":"Int J Mol Sci"},{"key":"752_CR171","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.phrs.2018.07.019","volume":"135","author":"N Griffin","year":"2018","unstructured":"Griffin N, Faulkner S, Jobling P, Hondermarck H. Targeting neurotrophin signaling in cancer: the renaissance. Pharmacol Res. 2018;135:12\u20137.","journal-title":"Pharmacol Res"},{"key":"752_CR172","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12943-024-02219-0","volume":"24","author":"Q Huang","year":"2025","unstructured":"Huang Q, Hu B, Zhang P, Yuan Y, Yue S, Chen X, Liang J, Tang Z, Zhang B. Neuroscience of cancer: unraveling the complex interplay between the nervous system, the tumor and the tumor immune microenvironment. Mol Cancer. 2025;24:24.","journal-title":"Mol Cancer"},{"key":"752_CR173","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.bbcan.2016.05.003","volume":"1866","author":"IE Demir","year":"2016","unstructured":"Demir IE, Tieftrunk E, Schorn S, Friess H, Ceyhan GO. Nerve growth factor & TrkA as novel therapeutic targets in cancer. Biochim Et Biophys Acta (BBA) Rev Cancer. 2016;1866:37\u201350.","journal-title":"Biochim Et Biophys Acta (BBA) Rev Cancer"},{"key":"752_CR174","doi-asserted-by":"publisher","first-page":"965","DOI":"10.3390\/cimb46020062","volume":"46","author":"G Ferraguti","year":"2024","unstructured":"Ferraguti G, Terracina S, Tarani L, Fanfarillo F, Allushi S, Caronti B, Tirassa P, Polimeni A, Lucarelli M, Cavalcanti L, et al. Nerve growth factor and the role of inflammation in tumor development. Curr Issues Mol Biol. 2024;46:965\u201389.","journal-title":"Curr Issues Mol Biol"},{"key":"752_CR175","doi-asserted-by":"publisher","first-page":"3225","DOI":"10.1038\/s41467-024-47633-6","volume":"15","author":"L Zhao","year":"2024","unstructured":"Zhao L, Lai Y, Jiao H, Huang J. Nerve growth factor receptor limits inflammation to promote remodeling and repair of osteoarthritic joints. Nat Commun. 2024;15:3225.","journal-title":"Nat Commun"},{"key":"752_CR176","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s13046-016-0395-y","volume":"35","author":"L Aloe","year":"2016","unstructured":"Aloe L, Rocco ML, Balzamino BO, Micera A. Nerve growth factor: role in growth, differentiation and controlling cancer cell development. J Exp Clin Cancer Res. 2016;35:116.","journal-title":"J Exp Clin Cancer Res"},{"key":"752_CR177","doi-asserted-by":"publisher","first-page":"510","DOI":"10.3390\/cancers3010510","volume":"3","author":"N Molloy","year":"2011","unstructured":"Molloy N, Read D, Gorman A. Nerve growth factor in cancer cell death and survival. Cancers. 2011;3:510\u201330.","journal-title":"Cancers"},{"key":"752_CR178","doi-asserted-by":"publisher","first-page":"784","DOI":"10.3390\/cancers11060784","volume":"11","author":"M Di Donato","year":"2019","unstructured":"Di Donato M, Cernera G, Migliaccio A, Castoria G. Nerve growth factor induces proliferation and aggressiveness in prostate cancer cells. Cancers. 2019;11:784.","journal-title":"Cancers"},{"key":"752_CR179","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13578-023-01008-4","volume":"13","author":"M Di Donato","year":"2023","unstructured":"Di Donato M, Giovannelli P, Migliaccio A, Castoria G. The nerve growth factor-delivered signals in prostate cancer and its associated microenvironment: when the dialogue replaces the monologue. Cell Bioscience. 2023;13:60.","journal-title":"Cell Bioscience"},{"key":"752_CR180","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s42003-020-01549-1","volume":"4","author":"W-Y Chen","year":"2021","unstructured":"Chen W-Y, Wen Y-C, Lin S-R, Yeh H-L, Jiang K-C, Chen W-H, Lin Y-S, Zhang Q, Liew P-L, Hsiao M, et al. Nerve growth factor interacts with CHRM4 and promotes neuroendocrine differentiation of prostate cancer and castration resistance. Commun Biol. 2021;4:22.","journal-title":"Commun Biol"},{"key":"752_CR181","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1016\/j.cmet.2022.10.012","volume":"34","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Lin C, Liu Z, Sun Y, Chen M, Guo Y, Liu W, Zhang C, Chen W, Sun J, et al. Cancer cells co-opt nociceptive nerves to thrive in nutrient-poor environments and upon nutrient-starvation therapies. Cell Metabol. 2022;34:1999\u20132017. e1910.","journal-title":"Cell Metabol"},{"key":"752_CR182","doi-asserted-by":"publisher","first-page":"2108653","DOI":"10.1002\/adma.202108653","volume":"34","author":"X Chu","year":"2022","unstructured":"Chu X, Zhuang H, Liu Y, Li J, Wang Y, Jiang Y, Zhang H, Zhao P, Chen Y, Jiang X, et al. Blocking cancer\u2013Nerve crosstalk for treatment of metastatic bone cancer pain. Adv Mater. 2022;34:2108653.","journal-title":"Adv Mater"},{"key":"752_CR183","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.apsb.2020.05.004","volume":"11","author":"T Jiang","year":"2021","unstructured":"Jiang T, Wang G, Liu Y, Feng L, Wang M, Liu J, et al. Development of small-molecule Tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers. Acta Pharm Sin B. 2021;11:355\u201372.","journal-title":"Acta Pharm Sin B"},{"key":"752_CR184","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41698-024-00686-8","volume":"8","author":"J Sheng","year":"2024","unstructured":"Sheng J, Chen H, Fu B, Pan H, Wang J, Han W. BPI-28592 as a novel second generation inhibitor for NTRK fusion tumors. Npj Precision Oncol. 2024;8:198.","journal-title":"Npj Precision Oncol"},{"key":"752_CR185","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1158\/1535-7163.MCT-17-1180","volume":"17","author":"H Tanaka","year":"2018","unstructured":"Tanaka H, Sase H, Tsukaguchi T, Hasegawa M, Tanimura H, Yoshida M, Sakata K, Fujii T, Tachibana Y, Takanashi K, et al. Selective TRK inhibitor CH7057288 against TRK Fusion-Driven cancer. Mol Cancer Ther. 2018;17:2519\u201329.","journal-title":"Mol Cancer Ther"},{"key":"752_CR186","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1111\/bph.15988","volume":"180","author":"S Koganemaru","year":"2022","unstructured":"Koganemaru S, Kawai T, Fuchigami H, Maeda N, Koyama K, Kuboki Y, Mukohara T, Doi T, Yasunaga M. Quantitative analysis of drug distribution in heterogeneous tissues using dual-stacking capillary electrophoresis\u2013mass spectrometry. Br J Pharmacol. 2022;180:762\u201374.","journal-title":"Br J Pharmacol"},{"key":"752_CR187","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1021\/acs.jmedchem.8b01092","volume":"62","author":"W Yan","year":"2018","unstructured":"Yan W, Lakkaniga NR, Carlomagno F, Santoro M, McDonald NQ, Lv F, Gunaganti N, Frett B, Li HY. insights into current Tropomyosin receptor kinase (TRK) inhibitors: development and clinical application. J Med Chem. 2018;62:1731\u201360.","journal-title":"J Med Chem"},{"key":"752_CR188","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/j.joca.2019.07.013","volume":"27","author":"DA Walsh","year":"2019","unstructured":"Walsh DA, Neogi T. A tale of two TrkA inhibitor trials: same target, divergent results. Osteoarthritis Cartilage. 2019;27:1575\u20137.","journal-title":"Osteoarthritis Cartilage"},{"key":"752_CR189","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/s41571-018-0113-0","volume":"15","author":"E Cocco","year":"2018","unstructured":"Cocco E, Scaltriti M, Drilon A. NTRK fusion-positive cancers and TRK inhibitor therapy. Nat Rev Clin Oncol. 2018;15:731\u201347.","journal-title":"Nat Rev Clin Oncol"},{"key":"752_CR190","first-page":"997","volume":"24","author":"F Doz","year":"2022","unstructured":"Doz F, van Tilburg CM, Geoerger B, H\u00f8jgaard M, \u00d8ra I, Boni V, Capra M, Chisholm J, Chung HC, DuBois SG, et al. Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumors. Neurooncology. 2022;24:997\u20131007.","journal-title":"Neurooncology"},{"key":"752_CR191","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1080\/13880209.2021.1998140","volume":"59","author":"T Sui","year":"2021","unstructured":"Sui T, Qiu B, Qu J, Wang Y, Ran K, Han W, Peng X. Gambogic amide inhibits angiogenesis by suppressing VEGF\/VEGFR2 in endothelial cells in a TrkA-independent manner. Pharm Biol. 2021;59:1564\u201373.","journal-title":"Pharm Biol"},{"key":"752_CR192","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2023.1197484","volume":"11","author":"L Gan","year":"2023","unstructured":"Gan L, Ji P, Zhang J-x, Chen H, Yao Y-s, Ren Z-k. Drug delivery system for the extended-release of larotrectinib based a biocompatible Fe-based metal-organic framework: synthesis, characterization, in vitro release properties and antitumor evaluation. Front Bioeng Biotechnol. 2023;11:1197484.","journal-title":"Front Bioeng Biotechnol"},{"key":"752_CR193","doi-asserted-by":"publisher","first-page":"100068","DOI":"10.1016\/j.medp.2024.100068","volume":"2","author":"C Xing","year":"2025","unstructured":"Xing C, Chen P, Hugnot J-P, Liu C. Targeting neural components in the tumor microenvironment as a novel therapeutic approach. Med Plus. 2025;2:100068.","journal-title":"Med Plus"},{"key":"752_CR194","first-page":"2031","volume":"17","author":"L Meng","year":"2018","unstructured":"Meng L, Liu B, Ji R, Jiang X, Yan X, Xin Y. Targeting the BDNF\/TrkB pathway for the treatment of tumors (Review). Oncol Lett. 2018;17:2031\u20139.","journal-title":"Oncol Lett"},{"key":"752_CR195","doi-asserted-by":"publisher","first-page":"e70138","DOI":"10.1111\/cns.70138","volume":"30","author":"M Lei","year":"2024","unstructured":"Lei M, Liu Q, Nie J, Huang R, Mei Y, Pan D, Chen Y, Liu W. Impact and mechanisms of action of BDNF on neurological Disorders, Cancer, and cardiovascular diseases. CNS Neurosci Ther. 2024;30:e70138.","journal-title":"CNS Neurosci Ther"},{"key":"752_CR196","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/s41586-023-06678-1","volume":"623","author":"KR Taylor","year":"2023","unstructured":"Taylor KR, Barron T, Hui A, Spitzer A, Yal\u00e7in B, Ivec AE, Geraghty AC, Hartmann GG, Arzt M, Gillespie SM, et al. Glioma synapses recruit mechanisms of adaptive plasticity. Nature. 2023;623:366\u201374.","journal-title":"Nature"},{"key":"752_CR197","doi-asserted-by":"publisher","first-page":"4685","DOI":"10.1038\/s41388-019-0756-z","volume":"38","author":"MJ Contreras-Z\u00e1rate","year":"2019","unstructured":"Contreras-Z\u00e1rate MJ, Day NL, Ormond DR, Borges VF, Tobet S, Gril B, Steeg PS, Cittelly DM. Estradiol induces BDNF\/TrkB signaling in triple-negative breast cancer to promote brain metastases. Oncogene. 2019;38:4685\u201399.","journal-title":"Oncogene"},{"key":"752_CR198","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.pjnns.2016.10.001","volume":"51","author":"J Siuda","year":"2017","unstructured":"Siuda J, Patalong-Ogiewa M, \u017bmuda W, Targosz-Gajniak M, Niewiadomska E, Matuszek I, J\u0119drzejowska-Szypu\u0142ka H, Rudzi\u0144ska-Bar M. Cognitive impairment and BDNF serum levels. Neurol Neurochir Pol. 2017;51:24\u201332.","journal-title":"Neurol Neurochir Pol"},{"key":"752_CR199","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3389\/fneur.2019.00515","volume":"10","author":"Y Jin","year":"2019","unstructured":"Jin Y, Sun LH, Yang W, Cui RJ, Xu SB. The role of BDNF in the neuroimmune axis regulation of mood disorders. Front Neurol. 2019;10:515.","journal-title":"Front Neurol"},{"key":"752_CR200","doi-asserted-by":"publisher","DOI":"10.1177\/1470320325141","author":"Y Zhang","year":"2026","unstructured":"Zhang Y, Chen Y, Wu K, Huang Z. Integrating exercise, music, and dance therapies in education to modulate the renin-angiotensin system: implications for childhood depression. J Renin-Angiotensin Aldosterone Syst. 2026. https:\/\/doi.org\/10.1177\/1470320325141.","journal-title":"J Renin-Angiotensin Aldosterone Syst"},{"key":"752_CR201","doi-asserted-by":"publisher","first-page":"4531","DOI":"10.1242\/dev.127.21.4531","volume":"127","author":"MJ Donovan","year":"2000","unstructured":"Donovan MJ, Lin MI, Wiegn P, Ringstedt T, Kraemer R, Hahn R, Wang S, Iba\u00f1ez CF, Rafii S, Hempstead BL. Brain derived neurotrophic factor is an endothelial cell survival factor required for intramyocardial vessel stabilization. Development. 2000;127:4531\u201340.","journal-title":"Development"},{"key":"752_CR202","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1101\/gad.346405","volume":"19","author":"N Wagner","year":"2005","unstructured":"Wagner N, Wagner K-D, Theres H, Englert C, Schedl A, Scholz H. Coronary vessel development requires activation of the TrkB neurotrophin receptor by the wilms\u2019 tumor transcription factor Wt1. Genes Dev. 2005;19:2631\u201342.","journal-title":"Genes Dev"},{"key":"752_CR203","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0092-8674(05)80088-1","volume":"75","author":"R Klein","year":"1993","unstructured":"Klein R, Smeyne RJ, Wurst W, Long LK, Auerbach BA, Joyner AL, Barbacid M. Targeted disruption of the TrkB neurotrophin receptor gene results in nervous system lesions and neonatal death. Cell. 1993;75:113\u201322.","journal-title":"Cell"},{"key":"752_CR204","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/s41583-023-00724-7","volume":"24","author":"W Koh","year":"2023","unstructured":"Koh W, Kwak H, Cheong E, Lee CJ. Gaba tone regulation and its cognitive functions in the brain. Nat Rev Neurosci. 2023;24:523\u201339.","journal-title":"Nat Rev Neurosci"},{"key":"752_CR205","doi-asserted-by":"publisher","first-page":"14439","DOI":"10.1073\/pnas.2435457100","volume":"100","author":"BM Stell","year":"2003","unstructured":"Stell BM, Brickley SG, Tang CY, Farrant M, Mody I. Neuroactive steroids reduce neuronal excitability by selectively enhancing tonic inhibition mediated by delta subunit-containing GABAA receptors. Proc Natl Acad Sci. 2003;100:14439\u201344.","journal-title":"Proc Natl Acad Sci."},{"key":"752_CR206","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1017\/S0033583524000179","volume":"58","author":"MA Micha\u0142owski","year":"2025","unstructured":"Micha\u0142owski MA, K\u0142opotowski K, Wiera G, Czy\u017cewska MM, Mozrzymas JW. Molecular mechanisms of the GABA type A receptor function. Q Rev Biophys. 2025;58:e3.","journal-title":"Q Rev Biophys"},{"key":"752_CR207","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.tcb.2022.08.004","volume":"33","author":"D Huang","year":"2023","unstructured":"Huang D, Alexander PB, Li Q-J, Wang X-F. Gabaergic signaling beyond synapses: an emerging target for cancer therapy. Trends Cell Biol. 2023;33:403\u201312.","journal-title":"Trends Cell Biol"},{"key":"752_CR208","first-page":"iv3","volume":"24","author":"R Barrow","year":"2022","unstructured":"Barrow R, Poulter JA, Finetti MA, Wilson E, Johnson CA, Stead L. Modulation of GABA neurotransmitter signalling impacts glioblastoma spheroid growth and response to standard treatment. Neurooncol. 2022;24:iv3-4.","journal-title":"Neurooncol"},{"key":"752_CR209","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1038\/s41586-024-08579-3","volume":"639","author":"T Barron","year":"2025","unstructured":"Barron T, Yal\u00e7\u0131n B, Su M, Byun YG, Gavish A, Shamardani K, Xu H, Ni L, Soni N, Mehta V, et al. GABAergic neuron-to-glioma synapses in diffuse midline gliomas. Nature. 2025;639:1060\u20138.","journal-title":"Nature"},{"key":"752_CR210","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/s41593-025-01917-2","volume":"28","author":"L Welberg","year":"2025","unstructured":"Welberg L. Et Tu. GABA? Nature Neuroscience. 2025;28:433\u2013433.","journal-title":"GABA? Nature Neuroscience"},{"key":"752_CR211","doi-asserted-by":"publisher","first-page":"9704","DOI":"10.1158\/0008-5472.CAN-07-2099","volume":"67","author":"A Takehara","year":"2007","unstructured":"Takehara A, Hosokawa M, Eguchi H, Ohigashi H, Ishikawa O, Nakamura Y, Nakagawa H. \u03b3-Aminobutyric acid (GABA) stimulates pancreatic cancer growth through overexpressing GABAA receptor \u03c0 subunit. Cancer Res. 2007;67:9704\u201312.","journal-title":"Cancer Res"},{"key":"752_CR212","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13046-025-03315-9","volume":"44","author":"M Xie","year":"2025","unstructured":"Xie M, Qin H, Liu L, Wu J, Zhao Z, Zhao Y, Fang Y, Yu X, Su C. GABA regulates metabolic reprogramming to mediate the development of brain metastasis in non-small cell lung cancer. J Exp Clin Cancer Res. 2025;44:61.","journal-title":"J Exp Clin Cancer Res."},{"key":"752_CR213","doi-asserted-by":"publisher","first-page":"172475","DOI":"10.1016\/j.ejphar.2019.172475","volume":"858","author":"M-M Ge","year":"2019","unstructured":"Ge M-M, Chen S-P, Zhou Y-Q, Li Z, Tian X-B, Gao F, Manyande A, Tian Y-K, Yang H. The therapeutic potential of GABA in neuron-glia interactions of cancer-induced bone pain. Eur J Pharmacol. 2019;858:172475.","journal-title":"Eur J Pharmacol"},{"key":"752_CR214","doi-asserted-by":"publisher","first-page":"14498","DOI":"10.1002\/cam4.6102","volume":"12","author":"TJ Li","year":"2023","unstructured":"Li TJ, Jiang J, Tang YL, Liang XH. Insights into the leveraging of GABAergic signaling in cancer therapy. Cancer Med. 2023;12:14498\u2013510.","journal-title":"Cancer Med"},{"key":"752_CR215","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41556-021-00839-y","volume":"24","author":"W Huang","year":"2022","unstructured":"Huang W, Cao L. Targeting GABA signalling for cancer treatment. Nat Cell Biol. 2022;24:131\u20132.","journal-title":"Nat Cell Biol"},{"key":"752_CR216","doi-asserted-by":"publisher","first-page":"5667","DOI":"10.1007\/s00018-021-03881-z","volume":"78","author":"AK Bhandage","year":"2021","unstructured":"Bhandage AK, Barragan A. GABAergic signaling by cells of the immune system: more the rule than the exception. Cell Mol Life Sci. 2021;78:5667\u201379.","journal-title":"Cell Mol Life Sci"},{"key":"752_CR217","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3390\/biomedicines11020254","volume":"11","author":"J Tian","year":"2023","unstructured":"Tian J, Kaufman DL. The GABA and GABA-Receptor system in Inflammation, Anti-Tumor immune Responses, and COVID-19. Biomedicines. 2023;11:254.","journal-title":"Biomedicines"},{"key":"752_CR218","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41556-021-00820-9","volume":"24","author":"D Huang","year":"2022","unstructured":"Huang D, Wang Y, Thompson JW, Yin T, Alexander PB, Qin D, Mudgal P, Wu H, Liang Y, Tan L, et al. Cancer-cell-derived GABA promotes \u03b2-catenin-mediated tumour growth and immunosuppression. Nat Cell Biol. 2022;24:230\u201341.","journal-title":"Nat Cell Biol"},{"key":"752_CR219","doi-asserted-by":"publisher","first-page":"123067","DOI":"10.1016\/j.lfs.2024.123067","volume":"357","author":"S Sun","year":"2024","unstructured":"Sun S, Chen X, Ding N, Zhang M, Li X, Chen L, Sun K, Liu Y. Gamma-aminobutyric acid-mediated neuro-immune interactions in glioblastoma: implications for prognosis and immunotherapy response. Life Sci. 2024;357:123067.","journal-title":"Life Sci"},{"key":"752_CR220","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/s41419-023-06219-8","volume":"14","author":"Z-g Chen","year":"2023","unstructured":"Chen Z-g, Shi X, Zhang X-x, Yang F-F, Li K-r, Fang Q, Cao C, Chen X-h. Neuron-secreted NLGN3 ameliorates ischemic brain injury via activating G\u03b1i1\/3-Akt signaling. Cell Death Dis. 2023;14:700.","journal-title":"Cell Death Dis"},{"key":"752_CR221","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.cell.2015.04.012","volume":"161","author":"S Venkatesh Humsa","year":"2015","unstructured":"Venkatesh Humsa S, Johung Tessa B, Caretti V, Noll A, Tang Y, Nagaraja S, Gibson Erin M, Mount Christopher W, Polepalli J, Mitra Siddhartha S, et al. Neuronal activity promotes glioma growth through Neuroligin-3 secretion. Cell. 2015;161:803\u201316.","journal-title":"Cell"},{"key":"752_CR222","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s11060-018-2967-5","volume":"140","author":"J Derks","year":"2018","unstructured":"Derks J, Wesseling P, Carbo EWS, Hillebrand A, van Dellen E, de Witt Hamer PC, Klein M, Schenk GJ, Geurts JJG, Reijneveld JC, Douw L. Oscillatory brain activity associates with neuroligin-3 expression and predicts progression free survival in patients with diffuse glioma. J Neurooncol. 2018;140:403\u201312.","journal-title":"J Neurooncol"},{"key":"752_CR223","doi-asserted-by":"publisher","first-page":"e12748","DOI":"10.7554\/eLife.12748","volume":"5","author":"P-H Kuhn","year":"2016","unstructured":"Kuhn P-H, Colombo AV, Schusser B, Dreymueller D, Wetzel S, Schepers U, Herber J, Ludwig A, Kremmer E, Montag D, et al. Systematic substrate identification indicates a central role for the metalloprotease ADAM10 in axon targeting and synapse function. eLife. 2016;5:e12748.","journal-title":"eLife"},{"key":"752_CR224","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.1002\/cam4.1538","volume":"7","author":"R Liu","year":"2018","unstructured":"Liu R, Qin XP, Zhuang Y, Zhang Y, Liao HB, Tang JC, Pan MX, Zeng FF, Lei Y, Lei RX, et al. Glioblastoma recurrence correlates with NLGN3 levels. Cancer Med. 2018;7:2848\u201359.","journal-title":"Cancer Med"},{"key":"752_CR225","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/nature24014","volume":"549","author":"HS Venkatesh","year":"2017","unstructured":"Venkatesh HS, Tam LT, Woo PJ, Lennon J, Nagaraja S, Gillespie SM, Ni J, Duveau DY, Morris PJ, Zhao JJ, et al. Targeting neuronal activity-regulated neuroligin-3 dependency in high-grade glioma. Nature. 2017;549:533\u20137.","journal-title":"Nature"},{"key":"752_CR226","first-page":"1660","volume":"24","author":"E van Kessel","year":"2022","unstructured":"van Kessel E, Berendsen S, Baumfalk AE, Venugopal H, Krijnen EA, Spliet WGM, van Hecke W, Giuliani F, Seute T, van Zandvoort MJE, et al. Tumor-related molecular determinants of neurocognitive deficits in patients with diffuse glioma. Neurooncology. 2022;24:1660\u201370.","journal-title":"Neurooncology"},{"key":"752_CR227","doi-asserted-by":"publisher","first-page":"2259130","DOI":"10.1080\/10641963.2023.2259130","volume":"45","author":"Y Wang","year":"2023","unstructured":"Wang Y, Xia M, Lu J, Wang T, Zhang X, Ntim M, Wang B. TIP60 mediates stress-induced hypertension via promoting glutamate dmPFC- to- vCA1 release. Clin Exp Hypertens. 2023;45:2259130.","journal-title":"Clin Exp Hypertens"},{"key":"752_CR228","doi-asserted-by":"publisher","first-page":"11738","DOI":"10.3390\/ijms241411738","volume":"24","author":"QG D\u2019Alessandris","year":"2023","unstructured":"D\u2019Alessandris QG, Menna G, Izzo A, D\u2019Ercole M, Della Pepa GM, Lauretti L, Pallini R, Olivi A, Montano N. Neuromodulation for brain tumors: myth or reality? A narrative review. Int J Mol Sci. 2023;24:11738.","journal-title":"Int J Mol Sci"},{"key":"752_CR229","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.3390\/ijms20071796","volume":"20","author":"L Corsi","year":"2019","unstructured":"Corsi L, Mescola A, Alessandrini A. Glutamate receptors and glioblastoma multiforme: an old route for new perspectives. Int J Mol Sci. 2019;20:1796.","journal-title":"Int J Mol Sci"},{"key":"752_CR230","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1038\/s41416-022-01863-x","volume":"127","author":"J Li","year":"2022","unstructured":"Li J, Xu Y, Zhu H, Wang Y, Li P, Wang D. The dark side of synaptic proteins in tumours. Br J Cancer. 2022;127:1184\u201392.","journal-title":"Br J Cancer"},{"key":"752_CR231","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1038\/nm.2453","volume":"17","author":"SC Buckingham","year":"2011","unstructured":"Buckingham SC, Campbell SL, Haas BR, Montana V, Robel S, Ogunrinu T, Sontheimer H. Glutamate release by primary brain tumors induces epileptic activity. Nat Med. 2011;17:1269\u201374.","journal-title":"Nat Med"},{"key":"752_CR232","doi-asserted-by":"publisher","first-page":"4503","DOI":"10.1038\/s41467-024-48757-5","volume":"15","author":"J Meyer","year":"2024","unstructured":"Meyer J, Yu K, Luna-Figueroa E, Deneen B, Noebels J. Glioblastoma disrupts cortical network activity at multiple Spatial and Temporal scales. Nat Commun. 2024;15:4503.","journal-title":"Nat Commun"},{"key":"752_CR233","doi-asserted-by":"publisher","first-page":"749","DOI":"10.3390\/ijms24010749","volume":"24","author":"EA Goethe","year":"2023","unstructured":"Goethe EA, Deneen B, Noebels J, Rao G. The role of hyperexcitability in gliomagenesis. Int J Mol Sci. 2023;24:749.","journal-title":"Int J Mol Sci"},{"key":"752_CR234","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12885-023-11797-z","volume":"24","author":"M Mastall","year":"2024","unstructured":"Mastall M, Roth P, Bink A, Fischer Maranta A, L\u00e4ubli H, Hottinger AF, Hundsberger T, Migliorini D, Ochsenbein A, Seystahl K, et al. A phase Ib\/II randomized, open-label drug repurposing trial of glutamate signaling inhibitors in combination with chemoradiotherapy in patients with newly diagnosed glioblastoma: the GLUGLIO trial protocol. BMC Cancer. 2024;24:82.","journal-title":"BMC Cancer"},{"key":"752_CR235","doi-asserted-by":"publisher","first-page":"112775","DOI":"10.1016\/j.celrep.2023.112775","volume":"42","author":"Y Han","year":"2023","unstructured":"Han Y, Goel P, Chen J, Perry S, Tran N, Nishimura S, Sanjani M, Chien C, Dickman D. Excess glutamate release triggers subunit-specific homeostatic receptor scaling. Cell Rep. 2023;42:112775.","journal-title":"Cell Rep"},{"key":"752_CR236","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/cbin.70005","volume":"49","author":"C Moriarty","year":"2025","unstructured":"Moriarty C, Gupta N, Bhattacharya D. Role of glutamate excitotoxicity in glioblastoma growth and its implications in treatment. Cell Biol Int. 2025;49:421\u201334.","journal-title":"Cell Biol Int"},{"key":"752_CR237","doi-asserted-by":"publisher","first-page":"14711","DOI":"10.1038\/s41598-020-71528-3","volume":"10","author":"T Sumi","year":"2020","unstructured":"Sumi T, Harada K. Mechanism underlying hippocampal long-term potentiation and depression based on competition between endocytosis and exocytosis of AMPA receptors. Sci Rep. 2020;10:14711.","journal-title":"Sci Rep"},{"key":"752_CR238","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/s41586-019-1564-x","volume":"573","author":"V Venkataramani","year":"2019","unstructured":"Venkataramani V, Tanev DI, Strahle C, Studier-Fischer A, Fankhauser L, Kessler T, K\u00f6rber C, Kardorff M, Ratliff M, Xie R, et al. Glutamatergic synaptic input to glioma cells drives brain tumour progression. Nature. 2019;573:532\u20138.","journal-title":"Nature"},{"key":"752_CR239","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3892\/ol.2022.13541","volume":"24","author":"J Tatsuoka","year":"2022","unstructured":"Tatsuoka J, Sano E, Hanashima Y, Yagi C, Yamamuro S, Sumi K, Hara H, Takada K, Kanemaru K, Komine\u2013Aizawa S, et al. Anti\u2013tumor effects of perampanel in malignant glioma cells. Oncol Lett. 2022;24:421.","journal-title":"Oncol Lett"},{"key":"752_CR240","doi-asserted-by":"publisher","first-page":"390","DOI":"10.3390\/jpm11050390","volume":"11","author":"A Salmaggi","year":"2021","unstructured":"Salmaggi A, Corno C, Maschio M, Donzelli S, D\u2019Urso A, Perego P, Ciusani E. Synergistic effect of perampanel and Temozolomide in human glioma cell lines. J Personalized Med. 2021;11:390.","journal-title":"J Personalized Med"},{"key":"752_CR241","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3892\/or.2022.8431","volume":"48","author":"C Yagi","year":"2022","unstructured":"Yagi C, Tatsuoka J, Sano E, Hanashima Y, Ozawa Y, Yoshimura S, Yamamuro S, Sumi K, Hara H, Katayama Y, Yoshino A. Anti\u2013tumor effects of anti\u2013epileptic drugs in malignant glioma cells. Oncol Rep. 2022;48:216.","journal-title":"Oncol Rep"},{"key":"752_CR242","doi-asserted-by":"publisher","first-page":"326","DOI":"10.3390\/brainsci13020326","volume":"13","author":"P Tabaee Damavandi","year":"2023","unstructured":"Tabaee Damavandi P, Pasini F, Fanella G, Cereda GS, Mainini G, DiFrancesco JC, et al. Perampanel in brain tumor-related epilepsy: a systematic review. Brain Sci. 2023;13:326.","journal-title":"Brain Sci"},{"key":"752_CR243","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.3390\/cells10051226","volume":"10","author":"F Lange","year":"2021","unstructured":"Lange F, H\u00f6rnschemeyer MF, Kirschstein T. Glutamatergic mechanisms in glioblastoma and Tumor-Associated epilepsy. Cells. 2021;10:1226.","journal-title":"Cells"},{"key":"752_CR244","doi-asserted-by":"publisher","first-page":"5365","DOI":"10.1158\/1078-0432.CCR-24-1849","volume":"30","author":"S Tobochnik","year":"2024","unstructured":"Tobochnik S, Regan MS, Dorotan MKC, Reich D, Lapinskas E, Hossain MA, Stopka S, Meredith DM, Santagata S, Murphy MM, et al. Pilot trial of perampanel on peritumoral hyperexcitability in newly diagnosed High-grade glioma. Clin Cancer Res. 2024;30:5365\u201373.","journal-title":"Clin Cancer Res"},{"key":"752_CR245","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12885-024-11846-1","volume":"24","author":"S Heuer","year":"2024","unstructured":"Heuer S, Burghaus I, Gose M, Kessler T, Sahm F, Vollmuth P, Venkataramani V, Hoffmann D, Schlesner M, Ratliff M, et al. PerSurge (NOA-30) phase II trial of perampanel treatment around surgery in patients with progressive glioblastoma. BMC Cancer. 2024;24:135.","journal-title":"BMC Cancer"},{"key":"752_CR246","doi-asserted-by":"publisher","first-page":"651","DOI":"10.3390\/biomedicines11030651","volume":"11","author":"J Rossi","year":"2023","unstructured":"Rossi J, Cavallieri F, Bassi MC, Biagini G, Rizzi R, Russo M, Bondavalli M, Iaccarino C, Pavesi G, Cozzi S, et al. Efficacy and tolerability of perampanel in brain Tumor-Related epilepsy: A systematic review. Biomedicines. 2023;11:651.","journal-title":"Biomedicines"},{"key":"752_CR247","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.1111\/bph.13919","volume":"174","author":"MR Dauvermann","year":"2017","unstructured":"Dauvermann MR, Lee G, Dawson N. Glutamatergic regulation of cognition and functional brain connectivity: insights from pharmacological, genetic and translational schizophrenia research. Br J Pharmacol. 2017;174:3136\u201360.","journal-title":"Br J Pharmacol"},{"key":"752_CR248","doi-asserted-by":"publisher","first-page":"106492","DOI":"10.1016\/j.phrs.2022.106492","volume":"185","author":"R Temmermand","year":"2022","unstructured":"Temmermand R, Barrett JE, Fontana ACK. Glutamatergic systems in neuropathic pain and emerging non-opioid therapies. Pharmacol Res. 2022;185:106492.","journal-title":"Pharmacol Res"},{"key":"752_CR249","doi-asserted-by":"publisher","first-page":"100187","DOI":"10.1016\/j.engmic.2024.100187","volume":"5","author":"H Shayista","year":"2025","unstructured":"Shayista H, Prasad MNN, Raj SN, Prasad A, Lakshmi S, Ranjini HK, Manju K, Ravikumara, Chouhan RS, Khohlova OY, et al. Complexity of antibiotic resistance and its impact on gut microbiota dynamics. Eng Microbiol. 2025;5:100187.","journal-title":"Eng Microbiol"},{"key":"752_CR250","first-page":"01","volume":"4","author":"M Shahidul Islam","year":"2020","unstructured":"Shahidul Islam M, Shirin M. Ceftriaxone, an empirical goldmine: a systematic review of randomized controlled trials. Mathews J Pharm Sci. 2020;4:01.","journal-title":"Mathews J Pharm Sci"},{"key":"752_CR251","doi-asserted-by":"publisher","first-page":"147032032513671","DOI":"10.1177\/14703203251367136","volume":"26","author":"M Li","year":"2025","unstructured":"Li M, Wang C, Liu H, Xu Z, Liu Y. MiRNAs in cancers and renin-angiotensin-aldosterone system: implications for chemoradiotherapy resistance. J Renin-Angiotensin-Aldosterone Syst. 2025;26:14703203251367136.","journal-title":"J Renin-Angiotensin-Aldosterone Syst"},{"key":"752_CR252","doi-asserted-by":"publisher","first-page":"813747","DOI":"10.3389\/fimmu.2021.813747","volume":"12","author":"J Peng","year":"2022","unstructured":"Peng J, Liang Q, Xu Z, Cai Y, Peng B, Li J, Zhang W, Kang F, Hong Q, Yan Y, Zhang M. Current Understanding of Exosomal MicroRNAs in glioma immune regulation and therapeutic responses. Front Immunol. 2022;12:813747.","journal-title":"Front Immunol"},{"key":"752_CR253","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s00432-014-1836-7","volume":"141","author":"C Liu","year":"2014","unstructured":"Liu C, Yang H, Xu Z, Li D, Zhou M, Xiao K, Shi Z, Zhu L, Yang L, Zhou R. microRNA-548l is involved in the migration and invasion of non-small cell lung cancer by targeting the AKT1 signaling pathway. J Cancer Res Clin Oncol. 2014;141:431\u201341.","journal-title":"J Cancer Res Clin Oncol"},{"key":"752_CR254","doi-asserted-by":"publisher","first-page":"101350","DOI":"10.1016\/j.mtbio.2024.101350","volume":"29","author":"X Chen","year":"2024","unstructured":"Chen X, Wang S, Hou W, Zhang Y, Hou Y, Tong H, Zhang X, Liu Y, Yang R, Li X, et al. Decellularized adipose matrix hydrogel-based in situ delivery of antagomiR-150-5p for rat abdominal aortic aneurysm therapy. Mater Today Bio. 2024;29:101350.","journal-title":"Mater Today Bio"},{"key":"752_CR255","doi-asserted-by":"publisher","first-page":"107216","DOI":"10.1016\/j.phrs.2024.107216","volume":"205","author":"H Xu","year":"2024","unstructured":"Xu H, Huang K, Shi M, Gong H, Han M, Tian W, Wang X, Zhang D. MicroRNAs in Helicobacter pylori-infected gastric cancer: function and clinical application. Pharmacol Res. 2024;205:107216.","journal-title":"Pharmacol Res"},{"key":"752_CR256","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1016\/j.ymthe.2024.12.045","volume":"33","author":"N Das","year":"2025","unstructured":"Das N, Bhat S, Fugo P, Dhawan A. MiRNAs as neuro-oncologic therapeutics: A narrative review. Mol Ther. 2025;33:2740\u201352.","journal-title":"Mol Ther"},{"key":"752_CR257","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.ncrna.2023.10.002","volume":"8","author":"I Gareev","year":"2023","unstructured":"Gareev I, Beylerli O, Tamrazov R, Ilyasova T, Shumadalova A, Du W, et al. Methods of miRNA delivery and possibilities of their application in neuro-oncology. Non-coding RNA Res. 2023;8:661\u201374.","journal-title":"Non-coding RNA Res"},{"key":"752_CR258","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s10571-024-01455-8","volume":"44","author":"F Ahmad","year":"2024","unstructured":"Ahmad F, Sudesh R, Ahmed AT, Haque S. Roles of HOTAIR long non-coding RNA in gliomas and other CNS disorders. Cell Mol Neurobiol. 2024;44:23.","journal-title":"Cell Mol Neurobiol"},{"key":"752_CR259","doi-asserted-by":"publisher","first-page":"12550","DOI":"10.1074\/jbc.M113.488593","volume":"289","author":"T Chiyomaru","year":"2014","unstructured":"Chiyomaru T, Fukuhara S, Saini S, Majid S, Deng G, Shahryari V, Chang I, Tanaka Y, Enokida H, Nakagawa M, et al. Long Non-coding RNA HOTAIR is targeted and regulated by miR-141 in human cancer cells. J Biol Chem. 2014;289:12550\u201365.","journal-title":"J Biol Chem"},{"key":"752_CR260","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1111\/jcmm.13512","volume":"22","author":"T Liu","year":"2018","unstructured":"Liu T, Zhang H, Zheng J, Lin J, Huang Y, Chen J, Yu Z, Guo L, Pan W, Xiong Y, Chen C. SPION-mediated miR\u2010141 promotes the differentiation of HuAESCs into dopaminergic neuron\u2010like cells via suppressing lncRNA\u2010HOTAIR. J Cell Mol Med. 2018;22:2299\u2013310.","journal-title":"J Cell Mol Med"},{"key":"752_CR261","doi-asserted-by":"publisher","first-page":"943","DOI":"10.2147\/OTT.S33766","volume":"6","author":"C Osipo","year":"2013","unstructured":"Osipo C, Zlobin, Olsauskas K. Gamma secretase inhibitors of Notch signaling. OncoTargets Therapy. 2013;6:943\u201355.","journal-title":"OncoTargets Therapy"},{"key":"752_CR262","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1158\/1078-0432.CCR-19-3420","volume":"26","author":"Y Otani","year":"2020","unstructured":"Otani Y, Yoo JY, Chao S, Liu J, Jaime-Ramirez AC, Lee TJ, Hurwitz B, Yan Y, Dai H, Glorioso JC, et al. Oncolytic HSV\u2013Infected glioma cells activate NOTCH in adjacent tumor cells sensitizing tumors to gamma secretase Inhibition. Clin Cancer Res. 2020;26:2381\u201392.","journal-title":"Clin Cancer Res"},{"key":"752_CR263","doi-asserted-by":"publisher","first-page":"1037929","DOI":"10.3389\/fnmol.2022.1037929","volume":"15","author":"C Zhang","year":"2022","unstructured":"Zhang C, Gao R, Zhou R, Chen H, Liu C, Zhu T, Chen C. The emerging power and promise of non-coding RNAs in chronic pain. Front Mol Neurosci. 2022;15:1037929.","journal-title":"Front Mol Neurosci"},{"key":"752_CR264","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s13258-019-00904-9","volume":"42","author":"C Liu","year":"2019","unstructured":"Liu C, Yang J, Liu H, Xia T, Zhang F. miR-300 mitigates cancer-induced bone pain through targeting HMGB1 in rat models. Genes Genomics. 2019;42:309\u201316.","journal-title":"Genes Genomics"},{"key":"752_CR265","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1007\/s12031-020-01607-7","volume":"70","author":"M Zhu","year":"2020","unstructured":"Zhu M, Wang L, Zhu J, Xu H, Wei K, Chen Q, Wu X, Miao X, Lu Z. MicroRNA-330 directs downregulation of the GABABR2 in the pathogenesis of pancreatic cancer pain. J Mol Neurosci. 2020;70:1541\u201351.","journal-title":"J Mol Neurosci"},{"key":"752_CR266","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mrrev.2018.05.001","volume":"777","author":"BL Parsons","year":"2018","unstructured":"Parsons BL. Multiclonal tumor origin: evidence and implications. Mutat Res Rev Mutat Res. 2018;777:1\u201318.","journal-title":"Mutat Res Rev Mutat Res"},{"key":"752_CR267","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semcancer.2018.07.004","volume":"53","author":"J Liu","year":"2018","unstructured":"Liu J. The dualistic origin of human tumors. Semin Cancer Biol. 2018;53:1\u201316.","journal-title":"Semin Cancer Biol"},{"key":"752_CR268","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.3390\/cells14181447","volume":"14","author":"MA Augello","year":"2025","unstructured":"Augello MA, Shadan N, D\u2019Amico G, Barone R, Caruso Bavisotto C, Scalia F, Vitale AM. Beneficial handling of molecular chaperones (Chaperonotherapy) in glioblastoma and neuroblastoma: novel therapeutic targets or potential agents? Cells. 2025;14:1447.","journal-title":"Cells"},{"key":"752_CR269","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.conb.2012.04.012","volume":"22","author":"C Liu","year":"2012","unstructured":"Liu C, Zong H. Developmental origins of brain tumors. Curr Opin Neurobiol. 2012;22:844\u20139.","journal-title":"Curr Opin Neurobiol"},{"key":"752_CR270","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/(SICI)1097-4547(19961015)46:2<164::AID-JNR4>3.0.CO;2-F","volume":"46","author":"A Yoshioka","year":"1996","unstructured":"Yoshioka A, Ikegaki N, Williams M, Pleasure D. Expression of N-methyl-D-aspartate (NMDA) and non-NMDA glutamate receptor genes in neuroblastoma, medulloblastoma, and other cell lines. J Neurosci Res. 1996;46:164\u201372.","journal-title":"J Neurosci Res"},{"key":"752_CR271","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1556\/2060.106.2019.22","volume":"106","author":"DN Nandakumar","year":"2019","unstructured":"Nandakumar DN, Ramaswamy P, Prasad C, Srinivas D, Goswami K. Glioblastoma invasion and NMDA receptors: a novel prospect. Physiol Int. 2019;106:250\u201360.","journal-title":"Physiol Int"},{"key":"752_CR272","first-page":"3181","volume":"31","author":"HL O U","year":"2011","unstructured":"O U HL. A T, C I: Silencing of selected glutamate receptor subunits modulates cancer growth. Anticancer Res. 2011;31:3181\u201392.","journal-title":"Anticancer Res"},{"key":"752_CR273","doi-asserted-by":"publisher","first-page":"5537","DOI":"10.1172\/JCI129502","volume":"129","author":"H Mohammadpour","year":"2019","unstructured":"Mohammadpour H, MacDonald CR, Qiao G, Chen M, Dong B, Hylander BL, McCarthy PL, Abrams SI, Repasky EA. \u03b22 adrenergic receptor\u2013mediated signaling regulates the immunosuppressive potential of myeloid-derived suppressor cells. J Clin Invest. 2019;129:5537\u201352.","journal-title":"J Clin Invest"},{"key":"752_CR274","doi-asserted-by":"publisher","first-page":"5086","DOI":"10.1172\/JCI133115","volume":"129","author":"I I\u00f1igo-Marco","year":"2019","unstructured":"I\u00f1igo-Marco I, Alonso MM. Destress and do not suppress: targeting adrenergic signaling in tumor immunosuppression. J Clin Invest. 2019;129:5086\u20138.","journal-title":"J Clin Invest"},{"key":"752_CR275","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1084\/jem.20100587","volume":"207","author":"CA Corzo","year":"2010","unstructured":"Corzo CA, Condamine T, Lu L, Cotter MJ, Youn J-I, Cheng P, Cho H-I, Celis E, Quiceno DG, Padhya T, et al. HIF-1\u03b1 regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment. J Exp Med. 2010;207:2439\u201353.","journal-title":"J Exp Med"},{"key":"752_CR276","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s12943-025-02441-4","volume":"24","author":"C Zhang","year":"2025","unstructured":"Zhang C, Guo X, Wang Y, Zhang S, Wang Z. The role of acetylcholine and its receptors in tumor immune regulation: mechanisms and potential therapeutic targets. Mol Cancer. 2025;24:231.","journal-title":"Mol Cancer"},{"key":"752_CR277","doi-asserted-by":"publisher","first-page":"189007","DOI":"10.1016\/j.bbcan.2023.189007","volume":"1878","author":"J Li","year":"2023","unstructured":"Li J, Che M, Zhang B, Zhao K, Wan C, Yang K. The association between the neuroendocrine system and the tumor immune microenvironment: emerging directions for cancer immunotherapy. Biochim Et Biophys Acta (BBA) Rev Cancer. 2023;1878:189007.","journal-title":"Biochim Et Biophys Acta (BBA) Rev Cancer"},{"key":"752_CR278","doi-asserted-by":"publisher","first-page":"507","DOI":"10.3390\/biom10040507","volume":"10","author":"A Siniavin","year":"2020","unstructured":"Siniavin A, Streltsova M, Kudryavtsev D, Shelukhina I, Utkin Y, Tsetlin V. Activation of \u03b17 nicotinic acetylcholine receptor upregulates HLA-DR and macrophage receptors: potential role in adaptive immunity and in preventing immunosuppression. Biomolecules. 2020;10:507.","journal-title":"Biomolecules"},{"key":"752_CR279","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.lfs.2016.12.015","volume":"172","author":"M Mashimo","year":"2017","unstructured":"Mashimo M, Iwasaki Y, Inoue S, Saito S, Kawashima K, Fujii T. Acetylcholine released from T cells regulates intracellular Ca 2+, IL-2 secretion and T cell proliferation through nicotinic acetylcholine receptor. Life Sci. 2017;172:13\u20138.","journal-title":"Life Sci"},{"key":"752_CR280","doi-asserted-by":"publisher","first-page":"eadx6539","DOI":"10.1126\/sciadv.adx6539","volume":"12","author":"MF Allega","year":"2026","unstructured":"Allega MF, Deshmukh R, Hillinger T, Akhmetshina A, Oudin A, Bielik R, Soloviev D, Villar VH, Ackermann T, Bourmeau G, et al. Steroid-dependent metabolic rewiring reveals novel therapeutic and imaging approaches for glioblastoma. Sci Adv. 2026;12:eadx6539.","journal-title":"Sci Adv"},{"key":"752_CR281","doi-asserted-by":"publisher","first-page":"3834","DOI":"10.1093\/brain\/awz331","volume":"142","author":"CJ Herting","year":"2019","unstructured":"Herting CJ, Chen Z, Maximov V, Duffy A, Szulzewsky F, Shayakhmetov DM, Hambardzumyan D. Tumour-associated macrophage-derived interleukin-1 mediates glioblastoma-associated cerebral oedema. Brain. 2019;142:3834\u201351.","journal-title":"Brain"},{"key":"752_CR282","doi-asserted-by":"publisher","first-page":"727707","DOI":"10.3389\/fphar.2021.727707","volume":"12","author":"L Zhou","year":"2021","unstructured":"Zhou L, Shen Y, Huang T, Sun Y, Alolga RN, Zhang G, Ge Y. The prognostic effect of dexamethasone on patients with glioblastoma: a systematic review and Meta-Analysis. Front Pharmacol. 2021;12:727707.","journal-title":"Front Pharmacol"},{"key":"752_CR283","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.3390\/cancers16071393","volume":"16","author":"P Scheffler","year":"2024","unstructured":"Scheffler P, Fung C, Momjian S, Koessinger D, H\u00e4ni L, Neidert N, Straehle J, Volz F, Schnell O, Beck J, El Rahal A. Dexamethasone in patients with glioblastoma: a systematic review and meta-analysis. Cancers. 2024;16:1393.","journal-title":"Cancers"},{"key":"752_CR284","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1158\/1078-0432.CCR-20-2291","volume":"27","author":"JB Iorgulescu","year":"2021","unstructured":"Iorgulescu JB, Gokhale PC, Speranza MC, Eschle BK, Poitras MJ, Wilkens MK, Soroko KM, Chhoeu C, Knott A, Gao Y, et al. Concurrent dexamethasone limits the clinical benefit of immune checkpoint Blockade in glioblastoma. Clin Cancer Res. 2021;27:276\u201387.","journal-title":"Clin Cancer Res"},{"key":"752_CR285","doi-asserted-by":"publisher","first-page":"566","DOI":"10.3340\/jkns.2019.0187","volume":"63","author":"A Komakech","year":"2020","unstructured":"Komakech A, Im J-H, Gwak H-S, Lee K-Y, Kim JH, Yoo BC, Cheong H, Park JB, Kwon JW, Shin SH, Yoo H. Dexamethasone interferes with autophagy and affects cell survival in irradiated malignant glioma cells. J Korean Neurosurg Soc. 2020;63:566\u201378.","journal-title":"J Korean Neurosurg Soc"},{"key":"752_CR286","doi-asserted-by":"publisher","first-page":"e1507668","DOI":"10.1080\/2162402X.2018.1507668","volume":"7","author":"KW Moyes","year":"2018","unstructured":"Moyes KW, Davis A, Hoglund V, Haberthur K, Lieberman NAP, Kreuser SA, Deutsch GH, Franco S, Locke D, Carleton MO, et al. Effects of tumor grade and dexamethasone on myeloid cells in patients with glioma. OncoImmunology. 2018;7:e1507668.","journal-title":"OncoImmunology"},{"key":"752_CR287","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s11060-018-2761-4","volume":"137","author":"D Dubinski","year":"2018","unstructured":"Dubinski D, Won S-Y, Gessler F, Quick-Weller J, Behmanesh B, Bernatz S, Forster M-T, Franz K, Plate K-H, Seifert V, et al. Dexamethasone-induced leukocytosis is associated with poor survival in newly diagnosed glioblastoma. J Neurooncol. 2018;137:503\u201310.","journal-title":"J Neurooncol"},{"key":"752_CR288","doi-asserted-by":"publisher","first-page":"634","DOI":"10.3171\/jns.2000.93.4.0634","volume":"93","author":"B Badie","year":"2000","unstructured":"Badie B, Schartner JM, Paul J, Bartley BA, Vorpahl J, Preston JK. Dexamethasone-induced abolition of the inflammatory response in an experimental glioma model: a flow cytometry study. J Neurosurg. 2000;93:634\u20139.","journal-title":"J Neurosurg"},{"key":"752_CR289","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.coph.2008.05.001","volume":"8","author":"M Levite","year":"2008","unstructured":"Levite M. Neurotransmitters activate T-cells and elicit crucial functions via neurotransmitter receptors. Curr Opin Pharmacol. 2008;8:460\u201371.","journal-title":"Curr Opin Pharmacol"},{"key":"752_CR290","doi-asserted-by":"publisher","first-page":"6142","DOI":"10.1038\/s41467-024-50478-8","volume":"15","author":"W Li","year":"2024","unstructured":"Li W, Pan L, Hong W, Ginhoux F, Zhang X, Xiao C, Li X. A single-cell pan-cancer analysis to show the variability of tumor-infiltrating myeloid cells in immune checkpoint Blockade. Nat Commun. 2024;15:6142.","journal-title":"Nat Commun"},{"key":"752_CR291","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.jointm.2024.01.008","volume":"4","author":"J Chen","year":"2024","unstructured":"Chen J, Sun W, Zhu Y, Zhao F, Deng S, Tian M, Wang Y, Gong Y. TRPV1: the key Bridge in neuroimmune interactions. J Intensive Med. 2024;4:442\u201352.","journal-title":"J Intensive Med"},{"key":"752_CR292","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.neuroscience.2023.12.012","volume":"538","author":"A Yoshida","year":"2024","unstructured":"Yoshida A, Nishibata M, Maruyama T, Sunami S, Isono K, Kawamata T. Activation of transient receptor potential vanilloid 1 is involved in both pain and tumor growth in a mouse model of cancer pain. Neuroscience. 2024;538:80\u201392.","journal-title":"Neuroscience"},{"key":"752_CR293","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.bbrc.2023.01.075","volume":"648","author":"K Tanaka","year":"2023","unstructured":"Tanaka K, Kondo T, Narita M, Muta T, Yoshida S, Sato D, Suda Y, Hamada Y, Tezuka H, Kuzumaki N, Narita M. Repeated activation of Trpv1-positive sensory neurons facilitates tumor growth associated with changes in tumor-infiltrating immune cells. Biochem Biophys Res Commun. 2023;648:36\u201343.","journal-title":"Biochem Biophys Res Commun"},{"key":"752_CR294","doi-asserted-by":"publisher","first-page":"174480692513715","DOI":"10.1177\/17448069251371549","volume":"21","author":"S-q Cai","year":"2025","unstructured":"Cai S-q, Zhang Y-x, Wang C, Gao Y, Wang T-y, Xu F-n, Liu Q-z, Yin J, Zhang Z-j, Zhang S, et al. Targeting sphingosine-1-phosphate receptor 1 alleviates neuropathic pain associated with pancreatic ductal adenocarcinoma in mice and inhibits tumor progression. Mol Pain. 2025;21:17448069251371549.","journal-title":"Mol Pain"},{"key":"752_CR295","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1038\/nm.2827","volume":"18","author":"K Stock","year":"2012","unstructured":"Stock K, Kumar J, Synowitz M, Petrosino S, Imperatore R, Smith ESJ, Wend P, Purf\u00fcrst B, Nuber UA, Gurok U, et al. Neural precursor cells induce cell death of high-grade Astrocytomas through stimulation of TRPV1. Nat Med. 2012;18:1232\u20138.","journal-title":"Nat Med"}],"container-title":["Experimental Hematology &amp; Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40164-026-00752-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40164-026-00752-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40164-026-00752-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T14:03:24Z","timestamp":1770386604000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40164-026-00752-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":295,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["752"],"URL":"https:\/\/doi.org\/10.1186\/s40164-026-00752-w","relation":{},"ISSN":["2162-3619"],"issn-type":[{"value":"2162-3619","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,5]]},"assertion":[{"value":"14 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18"}}